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ABSTRACT 
Background The increasing rate of resistance to antibiotics has become a global 
concern. High consumption and irrational use of antibiotics is contributing to this 
development. In Sweden sales data of antibiotics was available, but there was a lack of 
detailed knowledge about therapeutic indications and compliance with guidelines, 
especially concerning elderly residents in nursing homes. 
 
Aim The aim was to present the treatment of infections in outpatients and in the 
elderly in nursing homes, and further to develop and evaluate the effect of an 
educational intervention, aiming at improving treatment with antibiotics in Swedish 
nursing homes. The specific objectives were to: i) Present the treatment patterns 
regarding infectious diseases in outpatients (I) and elderly residents in nursing homes 
(II). ii) Through focus group discussions and collection of knowledge and attitude 
data, elucidate the decision making process for antibiotic prescribing in nursing 
homes (III), target the intervention and explore barriers and facilitators for 
behavioural change. iii) Evaluate the effect of the intervention on quantity and quality 
of prescribing in relation to available guidelines (IV) 
 
Methods Paper I and II are cross-sectional studies describing the prescribing pattern in 
outpatients in five counties and in 58 nursing homes in Sweden, respectively. In paper 
III mixed methods are used – focus group discussions with ten nursing assistants, ten 
nurses and six general practitioners, and a knowledge- and attitude questionnaire. The 
study design used in paper IV is a cluster randomised controlled trial evaluating an 
educational intervention targeting physicians and nurses concerning antibiotic 
prescribing in nursing homes in Sweden. 
 
Results In the outpatient setting, 59% of patients with infectious complaints were 
treated with antibiotics (Paper I). In nursing homes the corresponding figure was 84% 
(Paper II). Women with lower UTI were treated with a quinolone in 21% of the cases in 
the outpatient setting (Paper I) and 29% in nursing homes (Paper II). In 38% of the 
cases in nursing homes, an antibiotic was prescribed during an indirect contact with the 
physician. Half of the women with lower UTI in nursing homes, received a treatment 
which was not in line with the recommendations (Paper II). The focus group 
discussions (Paper III) have provided us with a perspective on the staffs’ own 
experiences with regard to infections in nursing homes. The educational intervention 
had a modest effect on most outcome variables, including the primary outcome - 
proportion of quinolones for lower UTI in women - but reduced the proportion of 
infections treated with an antibiotic by 12% (Paper IV).  
 
Conclusions In outpatients, the prescribing pattern in general seemed to be in 
accordance with the recommendations, although there is still some room for 
improvement. The educational intervention had a modest effect on most outcomes, 
including the primary outcome, but reduced the proportion of prescribed courses of 
antibiotics.  
 
Keywords: antibiotic prescribing, outpatients, nursing homes, educational intervention, 
Sweden 
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SAMMANFATTNING – ABSTRACT IN SWEDISH 
Antibiotikaförskrivning 
med fokus på särskilda boenden för äldre i Sverige 
Bakgrund Antibiotikaresistens är numer ett globalt folkhälsoproblem. En hög 
förskrivning och irrationell antibiotikaanvändning är kända bidragande orsaker till den 
ökade antibiotikaresistensen. När denna studie började fanns förskrivningsdata, baserat 
på uthämtade recept av antibiotika på apotek, men uppgifter om indikation kopplat till 
förskrivningen var bristfälliga inom öppenvården och i synnerhet var kännedomen om 
antibiotikaförskrivningen vid särskilda boenden för äldre liten. 
Syfte Att presentera förskrivningsmönstret av antibiotika kopplat till diagnos inom 
öppenvård samt på särskilda boenden för äldre (säbo), samt att utveckla och utvärdera 
en intervention riktad till sjuksköterskor och läkare med syfte att förbättra 
antibiotikaförskrivningen inom säbo i Sverige.  
Metod Den första studien var en deskriptiv studie som omfattade fem län där diagnos- 
och förskrivningsdata samlades in under en vecka i november 2000 för alla patienter 
som sökte med infektionssymtom inom öppenvården. Den andra studien var en 
deskriptiv studie där diagnos- och förskrivningsdata samlades in under tre månader 
2003 på 58 säbo. Den tredje studien genomfördes under 2003 och 2004 och bestod av 
två olika delar: fokusgruppdiskussioner med 10 undersköterskor, 10 sjuksköterskor och 
sex läkare med anknytning till säbo samt en kunskaps-attitydenkät kring 
urinvägsinfektioner. Den fjärde studien var en klusterrandomiserad studie indelad i en 
kontrollgrupp och en interventionsgrupp, varav den senare fick ta del av en 
utbildningsintervention för de vanligaste infektionerna på säbo för att se om 
förskrivningsmönstret kunde förändras i linje med då gällande behandlings-
rekommendationer. Datainsamlingen före interventionen genomfördes under 2003 och 
datainsamlingen efter interventionen 2005. 
Resultat Inom öppenvården fick 59% av patienterna som sökte för infektionssymtom 
antibiotika. På särskilda boenden för äldre fick 84% av de som registrerades i studien 
antibiotika. Kvinnor med nedre UVI fick en kinolon, som i normalfallet ej är 
rekommenderad för den indikationen, i 21% av fallen inom öppenvården, medan 29% 
av kvinnorna på särskilda boenden fick en kinolon på indikationen nedre UVI. På säbo 
var läkaren inte på plats vid 38% av förskrivningstillfällena. Hälften av kvinnorna med 
nedre UVI på säbo behandlades inte enligt rekommendationerna. Fokusgrupp-
diskussionerna gav oss personalens perspektiv på infektioner på säbo samt bidrog till 
utvecklingen av interventionen.  Utbildningsinterventionen hade en blygsam effekt på 
de förutbestämda utfallsvariablerna, inklusive på primärutfallet - andelen kinoloner 
förskrivna på indikationen nedre UVI hos kvinnor - men andelen infektioner som 
antibiotikabehandlades minskade med 12%. 
Slutsats Inom öppenvården pekade förskrivningsmönstret på en relativt god följsamhet 
till gällande rekommendationer även om vissa möjligheter till förbättring kunde ses. 
Utbildningsinterventionen hade en relativt blygsam effekt, men den totala andelen 
infektioner som antibiotikabehandlades minskade. 
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LIST OF ABBREVIATIONS 
 
ASB Asymptomatic bacteriuria 
ATC Anatomical therapeutic chemical classification system 
CAP Community acquired pneumonia 
CDAD Clostridium difficile associated disease 
cfu/mL Colony-forming units per milliliter 
DDD Defined daily dose i.e the assumed average maintenance dose per 
day for a drug used for its main indication in adults 
DDD/TIND Defined Daily Doses per 1000 inhabitants and day 
Deff Design effect 
DPS Diagnosis-prescribing study 
EARS-Net European antimicrobial resistance surveillance network 
ESBL Extended spectrum beta-lactamase-producing 
Enterobacteriaceae 
GAS Group A streptococci 
GP General practitioner 
ICC Intracluster correlation coefficient 
IUC Indwelling urinary catheter 
KA Knowledge- and attitude questionnaire 
MRSA Methicillin-resistant Staphylococcus aureus 
NHAP Nursing home acquired pneumonia 
NHQ Nursing home questionnaire 
PcV Phenoxymethylpenicillin, commonly known as penicillin V 
PRP Penicillin-resistant pneumococci 
RTI Respiratory tract infection 
S, I or R Categorisation of infectious agents as susceptible, intermediate or 
resistant to particular antibiotics 
SANT Swedish antibiotic nursing home trial 
Sida Swedish international development cooperation agency 
SSTI Skin- and soft tissue infection 
Strama Swedish strategic programme against antibiotic resistance 
UTI Urinary tract infection 
VRE Vancomycine-resistant enterococci 
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PREFACE 
During the early 90s I started to take extra work as a nursing assistant at different 
nursing homes. First I worked in my home municipality of Piteå and later on during my 
MSc in Pharmacy studies at Uppsala University, in the Uppsala municipality. I really 
enjoyed my extra work and found it very meaningful – you always felt appreciated by 
the elderly – which was a nice feeling. I remember one Christmas my mother said to 
me: “Do you really have to work this Christmas too?” I really wanted to work and so I 
did. At the different workplaces I have had different experiences, which seemed to be 
related to characteristics of the staff working there, rather than organisational or 
economic factors. During my MSc in Pharmacy studies I took a great interest in 
microbiology and infections: eventually more specifically in the use of antibiotics, 
although then at a global level. I went to Lao PDR to do a minor field study for Sida, 
Swedish international development cooperation agency, and there I studied drug sales 
at the pharmacies and found a very high and irrational dispensing of antibiotics.  
 
On my return to Sweden I found that there had been many studies on antibiotic use, 
infections and hygiene related to children and day care centres. Due to my background 
working in elderly care I felt I wanted to know more about the use of antibiotics among 
the elderly population. After my MSc in pharmacy studies I was admitted to Health 
Care Sciences postgraduate school at the Karolinska Institutet. Here I started to project 
the realisation of my studies on antibiotic use in Sweden and I was also working with 
data on antibiotic prescribing to outpatients, which was used in Paper I of this thesis. 
The research projects they could offer at the postgraduate school were however not in 
the research area on which I wished to focus. So I wrote an application and received a 
grant from Apoteket AB’s Fund for Research and Studies in Health Economics and Social 
Pharmacy (grant number 177/02).  When I started my doctoral studies I had a somewhat 
naive belief that I would find out the truth about antibiotic prescribing in nursing 
homes. The abbreviation of the name of the randomized controlled trial being a part of 
this thesis – Swedish Antibiotic Nursing home Trial – SANT – actually means “true” in 
Swedish. Learning more and more about the infectious panorama in outpatients and 
later on in nursing homes I chose to focus on the most common infections in nursing 
homes. In writing the project plan I believed that there was a consensus on how they 
should be treated. However the simple fact that the guidelines for treatment of urinary 
tract infections had not been updated since 1990, should have given me pause. 
Fortunately we had the time and the funding to do a pilot study before the main project 
started. During the pilot study my pharmacy world was turned upside down. The 
guidelines were not followed! And determining a diagnosis like lower urinary tract 
infection was not as straightforward as I thought - not in this patient group. I thought I 
had a project with infections that were easily diagnosed and simple to treat according to 
evidence based guidelines, and that any deviations there might be could be cured with a 
little input on the guidelines to the prescribers. I was wrong, but during the years I have 
worked within this thesis project, there has been some progress in evidence based 
medicine within the area of antibiotic prescribing. 
 
Tage Danielsson*, once said: Without doubt you are not sane. And yes, I have had 
doubts that I would ever finalise the work that I started, as life interrupted. During these 
*A famous Swedish actor, author, comedian and film director 
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years at the division of Global Health (IHCAR) I have had two wonderful children: 
Emma and Alice and I became the head of the five hospital pharmacies in Norrbotten 
county during the turbulent years of privatisation of Swedish pharmacies. This explains 
some of the years that I have worked with this thesis. My main paper about the 
intervention has taken a journey starting with British Medical Journal, BMJ, where it 
passed all the way to the hanging committee. 
 
Although I could not find A truth, I found many truths and also new questions that I 
have put together in this thesis about antibiotic prescribing, with a focus on nursing 
homes in Sweden. 
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1 BACKGROUND 
1.1 ANTIBIOTIC RESISTANCE 
The increasing rate of antimicrobial resistance has become an issue of global concern 
[1-3]. It is well recognised that consumption and irrational use of antibiotics is one 
major contributing factor to this development [1, 4-9]. Measures have been taken, both 
nationally and internationally, to contain this trend [1, 10, 11]. The Swedish strategic 
programme against antibiotic resistance (Strama) was founded in 1995 to work towards 
rational antibiotic use [11, 12].  
 
An increased resistance in some of our most common pathogens causing for example 
pneumonia, Streptococcus pneumoniae, urinary tract infections, UTI, Escherichia coli, 
and skin- and soft tissue infections, SSTI, Staphylococcus aureus, would mean an 
alteration in our treatment choices and eventually a lack of available antibiotics with 
which to treat. There are few new antibiotics being developed [13]. Consequences of 
antibiotic resistance are adverse events for the consumers, increased mortality and also 
excessive costs for the care providers [14, 15]. 
 
In Sweden the resistance rates are lower compared to many other countries [12]. But it 
has been shown that resistance is difficult to reverse, which means that it is necessary 
that measures be taken before the resistance rates begin to grow to levels that are 
difficult to manage [16]. Resistance in bacteria with compulsory notification under the 
Communicable Disease Act in Sweden are penicillin-resistant pneumococcal infection 
(PRP), Enterobacteriaceae producing extended spectrum beta-lactamases (ESBL), 
Vancomycine-resistant enterococci (VRE) and methicillin-resistant Staphylococcus 
aureus infection (MRSA). In Sweden the rates of PRP seem to have stabilised. 402 
cases of VRE were reported during 2009, which was a decrease from 2008, but still 
much more common than during the period 2000-2006 when 18-35 cases per year were 
reported. The number of reported ESBL and MRSA in 2009 has increased 
[Smittskyddsinstitutet - Swedish Institute for Communicable Disease Control]. The 
question is how much longer Sweden can contain the antibiotic resistance. 
 
European Antimicrobial Resistance Surveillance Network, EARS-Net, is a network of 
national surveillance systems in Europe. It is coordinated and funded by European 
Centre for Disease Prevention and Control. Their interactive database allows 
presentation of selected data in tables, figures and maps [17]. The figures 1, 2 and 3 
below are illustrative, both in the perspective of differences between the countries in 
the susceptibility pattern of some common pathogens to common antibiotics, and in the 
perspective that antibiotic resistance is not an isolated phenomenon, but a global 
concern that requires the collaboration of all countries to be able to curb the trend of 
increased antibiotic resistance. 
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Figure 1. Proportion of Penicillins (R+I) resistant Streptococcus pneumoniae isolates in participating 
countries in 2009. Source: EARS-Net  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Proportion of Fluoroquinolones (R+I) resistant Escherichia coli isolates in participating 
countries in 2009. Source: EARS-Net  
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Figure 3. Proportion of Methicillin resistant Staphylococcus aureus (MRSA) isolates in participating 
countries in 2009. Source: EARS-Net 
 
 
1.2 SOURCES FOR DRUG STATISTICS IN SWEDEN 
 Diagnosis-Prescription Survey 
Started in 1978. Gave outpatient data on diagnosis and treatment choices. Randomly 
selected physicians (around 30) were asked each week to participate in the survey for 
one week. The data could not be traced to a particular clinic, doctor or patient [18]. 
Participation was voluntary and due to low uptake – the survey was terminated in 2002. 
At that time electronic prescriptions had become common.  
 
 Prescription Surveys 
National prescription survey Sales on prescription from 1974 [19, 20]. The sample size 
of prescriptions has varied during the years. Since 1996 it has comprised 100% of sales 
excluding dose dispensed drugs. Since 1999 dose dispensed drugs were also included 
[21]. A new individual drug record was introduced in 2005 where name, personal 
identity number, date, drug, amount and dose is recorded and kept for 15 months. It 
also contains information about the identity and profession of the prescriber. It is 
mandatory, but consent has to be given to let the physician or pharmacy personnel have 
access to the record [22-23]. Since 2009, Apotekens Service, has had the legal 
responsibility to collect and distribute statistics on prescribed drugs in Sweden.  
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Jämtland survey Register on individual purchase of drugs by 1/7 of the population in 
the county of Jämtland (around 18 000 people). Data has been collected since 1970 
[24]. 
 
Tierp survey started in 1971 and is based on the inhabitants in Tierp municipality 
(around 20 000 people). The database contains individual information on purchased 
prescribed drugs, but also on health care utilisation [25]. 
 
 Sales Statistics on Drugs has been available in Sweden since 1975 [21]. 
 
1.3 ANTIBIOTIC PRESCRIBING  
In a global context, Sweden is a low-prescribing country with respect to antibiotics [6, 
26]. Reliable data on sales statistics of antibiotics is available in Sweden [21, 27] and 
studies on antibiotic prescribing have been conducted in outpatient care [28-30]. In 
outpatient care, sales statistics has varied between different counties from 9.7 to 13.7 
DDD per 1000 inhabitants and day in 2010 [27 and Appendix I]. In DDD per 1000 
inhabitants and day, there has been a decrease in antibiotic sales in outpatients in all 
groups except for pivmecillinam,  nitrofurantoin, isoxazolylpenicillins and 
trimethoprim-sulfonamides. PcV represents the highest proportion of all antibiotics 
prescribed in Sweden in outpatient care, followed by tetracyclines, figure 4.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Antibiotic sales in outpatient care 2005-2009. Source: 2005-2008 Apoteket AB, Xplain 
Statistics. 2009-2010 Apotekens Service AB, Concise. 
Antibiotic sales in outpatient care 2005-2009
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The sales for antibiotics commonly prescribed for RTI in outpatients are dominated by 
PcV, followed by doxycycline, figure 5. There is a wide variation of RTI-antibiotics 
within the country in number of prescriptions per 1000 inhabitants where it ranged 
from 146-258 in 2009 [31]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. Antibiotic sales for respiratory tract infections in outpatient care between 2000-2009. Source: 
2000-2008 Apoteket AB, Xplain Statistics. 2009 Apotekens Service AB, Concise. 
 
Antibiotics commonly prescribed for UTIs in women show a trend towards less use of 
quinolones and trimethoprim in favour of an increase in pivmecillinam and 
nitrofurantoin, which is in line with current recommendations, figure 6.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6. Antibiotics for urinary tract infections in outpatient care, women  18 years. Prescriptions per 
1000 inhabitants and year between 2000-2009. Source: 2000-2008 Apoteket AB, Xplain Statistics. 2009-
2010 Apotekens Service AB, Concise. Presented by Strama. 
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Thus, when this project started sales data for antibiotics and resistance patterns were 
available, but after the ending of the diagnosis prescription survey, detailed knowledge 
about treatment patterns for different diagnoses would not be available. Little was 
known about the prescribing process as well as on actual use, in particular concerning 
the institutionalized elderly. The National Board of Health and Welfare had called for 
action in this field [10]. 
 
1.4 A SHORT OVERVIEW OF AETIOLOGY, ANTIMICROBIAL 
SUSCEPTIBILITY AND RECOMMENDED THERAPY FOR 
PNEUMONIA, UTI AND SSTI. 
All recommendations mentioned here are for empiric treatment in adults, without any 
complicating factors. Medical staff is referred to the original sources of 
recommendations for a complete picture. 
 
1.4.1 Pneumonia 
The most common pathogen causing pneumonia in both adults and elderly is 
Streptococcus  pneumoniae. The distribution of pathogens in outpatients in Sweden and 
in hospital-based studies of elderly patients in different countries is described in table 1 
below [32, 33].  
 
Table 1. Reported frequencies of the most commonly isolated microorganisms for community acquired 
pneumonia, CAP, and nursing home acquired pneumonia, NHAP. 
Pathogen CAP* 
(%) 
CAP † 
(%)  
NHAP†  
(%) 
Streptococcus pneumoniae 26 5-58 4-30 
Haemophilus influenzae 17 2-14 0-2 
Legionella pneumophilia 0 0-15 0-1 
Mycoplasma pneumoniae 6 1-13 1 
Chlamydia pneumoniae 3 0-28 0-18 
*Lagerström et al. 2003. 82 patients with radiographically proven CAP and 95 patients without 
infiltrates in Sweden. Excluded patients <10 years, mean age 51 years (range 10-84 years) [32]. 
†Janssens and Krause 2004, Review [33]. 
 
 
 
 
The resistance rates for common antibiotics are low in Sweden both for S. pneumoniae 
and H. influenzae, figure 7 and 8.  
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Figure 7. Resistance rates in S. pneumoniae 2002 - 2009. Source: Smittskyddsinstitutet (Swedish 
Institute for Communicable Disease Control). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                * beta-lactamase negative ampicillin-resistant 
                    † loracarbef 1999-2006, cefaklor 2007-2009 
                     ‡ nt, not tested 
Figure 8. Resistance rates in H. influenzae 1999 - 2009. Nalidixic acid indicates quinolone resistance. 
Source: Smittskyddsinstitutet (Swedish Institute for Communicable Disease Control). 
 
For empirical treatment of suspected pneumonia, PcV 1g x 3 for 7-10 days is the first-
line choice. Doxycycline for 7 days (200 mg day one, and 100 mg the following days) 
is recommended if there is type I allergy to penicillins or therapy failure. If the patient 
has a chronic obstructive pulmonary disease, COPD, or other factors indicating H. 
influenzae, amoxicillin 500 mg x 3 or a tetracycline is recommended. Immunization 
against pneumococcal pneumonia and influenza is recommended for people 65 years 
of age and others with certain risk factors such as chronic pulmonary or cardiovascular 
diseases [34].  
 
1.4.2 UTI 
E. coli is the most common pathogen causing UTI in Sweden and abroad [35-37]. 
Opportunistic pathogens such as Klebsiella spp., Proteus spp. and enterococci are more 
frequent in the elderly, table 2. 
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Table 2. Distribution of pathogens in urine cultures. 
 
Culture results ECO.SENS (18-65 years)* 
% 
No. of cultures = 4734 
Positive urine cultures in 
Kalmar and Växjö (65 years)† 
% 
No of cultures 
Escherichia coli 53.3 47.0 
Proteus  mirabilis 4.4 5.5 
Klebsiella spp. 2.2 7.5 
Other Enterobacteriaceae 2.7  4 
Staphylococcus 
saprophyticus 
2.5 0.4 
Other pathogens‡ 4.1 15 (enterococci =11) 
Non-pathogens 18.9 15.5§ 
Negative culture 11.9 Only positive included 
* Results from urine culture in the ECO.SENS study including women 15-65 years with 
symptoms of uncomplicated lower UTI in 16 European countries and Canada between Jan 1999 
and Dec 2000 [35]. 
† Results from positive urine cultures from microbiology laboratories in Kalmar and Växjö, 
Sweden 1999 (should be mainly upper and complicated UTI, men included) [36]. 
‡ Pseudomonas spp. and enterococci. 
§ Including S. aureus and C.  albicans, which could be contamination, but they can in exceptional 
cases cause UTIs.  
 
 
 
While the aetiology of lower UTI has not changed substantially over the years in 
different countries, the susceptibility pattern has changed. Therefore, in the new 
Swedish guidelines from 2007, trimethoprim was no longer considered a first-line 
choice in the empirical treatment of lower UTI in women. The first line choice of 
treatment needs to be reconsidered on a regular basis and thus local microbiology 
laboratories have an important role in providing updated information about the local 
resistance pattern. In long-term care facilities where urinary catheter is common (7%) 
and around 38 % had recently taken or were currently receiving antibiotics, 
opportunistic pathogens are more common [38, 39]. The resistance patterns in E. coli 
for common UTI-antibiotics in Sweden are presented in figure 9. 
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Figure 9. Resistance rates in E. coli 2002 - 2009. Nalidixic acid indicates quinolone resistance. Source: 
Smittskyddsinstitutet (Swedish Institute for Communicable Disease Control). 
 
An overview of the recommended empirical choice of therapy for lower UTI in women 
is presented in table 3 [40].  
 
Table 3. Recommended therapy for lower UTI in women. 
 
Antibiotics Dose Treatment duration  
(days) 
First-line therapy     
 pivmecillinam 400 mg x 2  
200 mg x 3 
200 mg x 2 
3*  
5  
7  
 nitrofurantoin 50 mg x 3 5 
Second-line therapy      
 
 
trimethoprim 160 mg x 2 
300 mg x 1 
3 
3 
 cephadroxil 0,5 g x 2 el 1 g x 1 5 
 cephalexin 0,5 g x 2 5 
* Women <50 years with sporadic lower UTI can be treated for three days, while women >50 should be 
treated for five to seven days. Source: Medical Products Agency – treatment recommendations for lower 
UTI in women, 2007 [40]. 
 
Treatment of UTI in men is different, and always seen as a complicated UTI as the 
prostate gland may be involved. Treatment choices are ciprofloxacin 500 mg x 2 or 
trimethoprim 160 mg x 2 or trimethoprim-sulfonamide 160/800 mg x 2 for 14 days.  
 
1.4.3 Skin- and soft tissue infections 
Staphylococcus aureus is the most common pathogen causing skin and soft tissue 
infections, SSTI, table 4 [41, 42]. 
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Table 4. Pathogens in skin- and soft tissue infections 
 
Pathogen Primary SSTI*, n=119 
% 
SSTI†, n=6548 
% 
Staphylococcus aureus 60.5 53.6 (incl. CoNS§ 7.3 
and MRSA|| 0.3) 
Staphylococcus 
lugdunensis 
14.3 2.6 
Enterobacteriaceae 
spp. 
33.0 10.1 
Anaerobic bacteria‡ 16.0 10.5 
Gram positives 5.9 6.3 
Other 0 11 
* Sjölund and Kahlmeter 2008, Sweden. Primary SSTI included, not secondary to e.g. trauma. For 
comparability the table only represents the 119 positive samples of the 175 samples taken from Nov 2006 
to Apr 2007 with 78 males 97 females, mean age 43 years (range 1-99) [41]. 
† Medical products agency, Sweden. Isolates from inpatients and outpatients 2007. In recommendations 
for treatment of SSTI, 2009 [42].  
‡  Including facultative anaerobic streptococci 
§ coagulase-negative staphylococci 
|| Methicillin-resistant Staphylococcus aureus 
 
 
The resistance rates in S. aureus are presented below in figure 10. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10. Resistance rates in S. aureus 2001 - 2009. Source: Smittskyddsinstitutet (Swedish Institute for 
Communicable Disease Control). 
 
Antibiotic treatment for SSTI is generally only indicated for erysipelas or if the patient 
has a poor general condition, fever or disseminated infection. For empirical treatment 
of SSTIs suspected to be caused by S. aureus, isoxazolylpenicillin 750-1000 mg x 3 is 
recommended. In erysipelas, caused by group A streptococci, GAS, the recommended 
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treatment is PcV 1g x 3 for 10 days or if there is type I allergy to penicillins, 
clindamycine 300 mg x 3. Antibiotic treatment of hard-to-heal leg ulcers is seldom 
motivated if not GAS has been isolated or disseminated infection is suspected [42]. 
 
1.5 ANTIBIOTIC PRESCRIBING AND NURSING HOMES 
The number of people living in special forms of housing in Sweden, including nursing 
homes, has decreased from 115 500 (7.5% of the population 65 years) in 2002 to 95 
400 (5.7% of the population 65 years) in 2009 [43]. The exact number of special 
forms of housing for the elderly in Sweden is not known, but in 2008 the National 
Board of Health and Welfare estimated this number to 2596 [44]. Approximately 70% 
of those living in nursing homes are women and around 80% are 80 years or above 
[45]. Elderly people are often more susceptible to infections than the population in 
general. During the last decade, the elderly, 65 years, have had the highest prevalence 
of dispensed antibacterials for systemic use, with the exception of the age group 0-4 
years [31]. Seasonal variation in antibiotic sales to the elderly over 80 years of age is 
low, which is illustrated in figure 11. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 11. The sales of antibacterial drugs for systemic use in outpatient care for patients over 80 years 
of age. Prescriptions per 1000 inhabitants and month from January 2002 to December 2004. Source: 
Xplain-statistics, Apoteket AB. 
 
 
The use of antibiotics is greater in women than in men, both in the elderly and in the 
population as a whole [27]. The most common indication for antibiotics in long-term 
care facilities is UTI [46-50]. Asymptomatic bacteriuria, ASB, is common in the 
elderly and in nursing homes a prevalence of 25-50% in women and 15-40% in men 
has been found [51, 52].  In Infectious Diseases Society of America guidelines, ASB is 
defined in asymptomatic women, as two consecutive voided urine specimens with 
isolation of the same bacterial strain in quantitative counts 105 colony-forming units 
(cfu) per mL. For asymptomatic men, bacteriuria is defined as a single, clean-catch, 
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voided urine specimen with one bacterial species isolated in a quantitative count 105 
cfu/mL. For women and men, a single catheterized urine specimen with one bacterial 
species isolated in a quantitative count greater than or equal to102 cfu/mL defines 
bacteriuria [53]. In both women and men with long-term indwelling urinary catheters, 
almost all have bacteriuria [54]. In elderly, ASB is a benign condition [55, 56] which 
should generally not be treated with antibiotics [57].  
 
Treatment of infections in the elderly requires well organised diagnostic measures and 
treatment guidelines as symptoms and signs of infection are usually indistinct and can 
appear as, for example, functional disorders such as confusion, falling or increasing 
incontinence [58, 59]. As a patient group, the elderly are vulnerable and generally have 
a high consumption of pharmaceuticals [60, 61]. Moreover, resistance rates are high in 
long-term care facilities [62]. The risk of Clostridium difficile associated disease, 
CDAD, is higher in nursing homes residents than others, due to advanced age, frequent 
hospitalisation and a high exposure to antibiotics [63]. In a nationwide study in 1995 
the annual incidence of community associated CDAD in Sweden was median 20; range 
in different counties 5-47 per 100,000 inhabitants. The hospital associated CDAD was 
27; range 17-51 per 100,000 bed-days [64]. As sales statistics of antibiotics showed a 
decrease in the population as a whole in Sweden since 1993, but an increase in people 
above 80 years of age, this further supported the need for studies on the use of 
antibiotics in the elderly [65]. Previously published studies on infections and antibiotic 
prescribing in Swedish nursing homes, have indicated a need for educational efforts on 
behalf of the nursing home personnel concerning infections [46, 47]. 
 
There were only a few studies on antibiotics in the Swedish context, which had focused 
on the situation for the institutionalised elderly. One of the problems with statistics on 
drug prescribing in nursing homes, is that some of the antibiotics are ordered for the 
nursing homes and not for an individual. To our knowledge there were three published 
studies that had described the indications for antibiotic use in nursing homes in Sweden 
when we started to plan for this project [46, 47, 66]. The problem was that they were 
relatively small and/or local, which made it difficult to generalise the results. However, 
their findings suggested that nursing homes should be of particular concern and pointed 
out a potential irrational use of quinolones [46]. Internationally there were also some 
studies concerning antibiotic use for nursing home residents [48-50, 67, 68]. Due to 
differences in health care and guidelines for antibiotic use, comparisons concerning 
treatment and recommendations are often difficult to make [47-49, 67]. In 2005 an 
intervention study in Canada and USA on antibiotic prescribing for suspected UTI in 
nursing home residents, was published with similar methodology to ours [69].  
 
 
1.6 CHANGING PRESCRIBING BEHAVIOUR 
Approaches to deal with problems in the prescribing of drugs and ways of influencing 
the prescribing behaviour have varied. For example, the National Board of Health and 
Welfare have been working on the development of quality indicators and criteria for 
drug use in the elderly [70]. Beers et al. 1997 have also developed criteria, but they 
define inappropriate medication rather than appropriate [71]. Another approach that has 
been used, is to gather local experts for their opinions, for example that authorities or 
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other organisations arrange consensus meetings with following dissemination of 
guidelines or the multidisciplinary drug reviews in nursing homes or [34, 40, 42, 53, 
72].  
 
Earlier studies have generally used the amount of pharmaceuticals (number of 
pharmaceuticals or the dose) as an indicator for rational prescribing and assumed “the 
lower the better” [73]. Our hypothesis was that the complex process of prescribing 
antibiotics requires more sophisticated methods to measure the quality, than simply 
assuming that a low consumption of antibiotics equals a high quality of prescribing. 
 
Changing professional behaviour is a complex process, where theories of change as 
well as theories of continuing education need to be considered [74-76]. Prochaska’s 
stages of change model postulates that people are in five different stages based on their 
readiness to change: precontemplation, contemplation, preparation, action and 
maintenance [77]. These stages of change are part of the transtheoretical model, which 
offers a framework for understanding and intervening in human behavioural change. 
The other two parts being process of change and level of change [78]. Initially its main 
application was within the area of addictive behaviours. However, more recently it has 
been suggested for tailoring interventions for continuing medical education [79, 80]. 
Shirazi et al. 2009 used a modified Prochaska model where the stages were reduced to 
three: attitude, intention and action [81, 82]. The results suggest that the modified 
Prochaska model could be used for improving general practitioners’ skills in 
management of depressive disorders. Basically what the Prochaska model would 
suggest in our context is that a successful intervention must first assess the stages of 
readiness to change in which the participants are situated and provide means to assist 
them from one stage to another and thus promote change. 
 
Experience from the USA suggests that sustainable changes have to involve the 
physician and the nurse responsible for the patient, and that information exchange and 
changes in behaviour are most easily achieved through meetings between people [83-
86]. There are also results from Sweden that encourage multidisciplinary team 
interventions [87, 88]. Social and behavioural science has provided us with theories and 
helpful information on how to change behaviour and thus develop successful 
interventions [89, 90]. Systematic reviews on changing professional practice, suggest 
that a combination of intervention strategies is crucial for successful results [91-95]. A 
Cochrane review, concerning improvement of antibiotic prescribing, points out that the 
selection of a successful intervention is condition and situation specific. Although 
cautious in their conclusions, they suggest that more complex intervention strategies in 
general seem to be more effective than simple approaches, such as distribution of 
guidelines only, didactic educational meetings, and audit and feedback [96]. According 
to a review in 2006 the effect that could be expected for an intervention targeting 
antibiotic treatment, is around the magnitude of 10%. Addressing the treatment 
decision, including 34 studies, mostly respiratory tract infections, RTI median: -8.9% 
(interquartile range (IQR) -12.4% to -6.7%) and those addressing the antibiotic 
selection decision (26 studies, RTI or UTI) median 10.6% (IQR 3.4% to 18.2%) [97]. 
 
The diagnosis-prescription survey had provided information on the percentage of 
patients with infectious symptoms that were prescribed an antibiotic and the indication 
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for specific antibiotics. But problems with this survey had been a low uptake, and that 
the results could not be traced to a certain clinic, doctor or patient, thus making it 
difficult to evaluate and improve the prescribing pattern where necessary. A 
complement to the diagnosis-prescription survey was needed. Since 2005 the national 
prescription database has contained all prescription-drugs dispensed at the pharmacy. 
However, the indication is not registered. 
 
The increase in antibiotic prescription for the elderly and the lack of national studies in 
the area, were the main reasons for initiating the study, which we refer to as the 
Swedish Antibiotic Nursing home Trial (SANT). It was a collaborative project between 
Karolinska Institutet, Strama (The Swedish Strategic Programme for the Rational use 
of Antimicrobial Agents) [11, 12] and Apoteket AB (The national corporation of 
Swedish pharmacies). In addition, the study was linked to an EU-funded project “A 
framework and tools to develop effective quality improvement programmes in 
European healthcare” (QLRT-2001-00657), where quality improvement projects from 
seven countries were linked together in order to build on the complementary strength of 
the partners. This randomised controlled intervention study falls within the area of 
pharmacoepidemiological intervention studies. The overall aim of SANT was to 
describe the prescribing of antibiotics in nursing homes for the elderly, and to develop 
and evaluate an educational intervention, targeting physicians and nurses working in 
nursing homes, as a means of quality improvement with regard to prevention and 
treatment of infections. The major part of this thesis project employs data derived from 
the SANT-study. 
 
To elucidate different aspects of the treatment of infectious diseases in the 
institutionalised elderly in a health system’s research perspective, we found 
interdisciplinary work important, thus researchers with several professional 
backgrounds were included in the study group. 
 
The term “special forms of housing” has been debated in Sweden and according to 
Lennarth Johansson, 2002, at the elderly unit of the National Board of Health and 
Welfare, this is more than an academic problem. The confusion of concepts leads to 
difficulties in comparing municipality care, causes problems in the work of the 
regulatory authorities and also affects the legal security of the residents [98 and 
personal communication 2011]. The term nursing home is in this thesis used for special 
forms of housing for the elderly where the residents have common health care 
personnel and have the opportunity to eat in a common dining room. 
 
2 AIM AND OBJECTIVE OF THE THESIS 
2.1 MAIN AIM AND OBJECTIVE 
The aim was to present the treatment of infections in outpatients and in the elderly in 
nursing homes, and further to develop and evaluate the effect of an educational 
intervention aiming at improving treatment with antibiotics in Swedish nursing 
homes. 
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2.2 SPECIFIC OBJECTIVES 
The specific objectives were to: 
 Present the treatment patterns regarding infectious diseases in outpatients (I) 
and elderly residents in nursing homes (II).  
 Through focus group discussions and collection of knowledge- and attitude 
data, elucidate the decision making process for antibiotic prescribing in 
nursing homes (III), target the intervention and explore barriers and 
facilitators for behavioural change. 
 Evaluate the effect of the intervention on quantity and quality of prescribing in 
relation to available guidelines (IV) 
3 MATERIAL AND METHODS 
3.1 STUDY OUTLINE 
3.1.1 Outpatient study 
A cross-sectional study conducted during one week in November 2000, where 
outpatient diagnosis-prescribing data was analysed in five different counties in 
Sweden. 
3.1.2 Swedish Antibiotic Nursing home Trial - SANT 
Phase 0: Pilot study and focus group discussions 
Phase I: Baseline study i.e diagnosis-prescribing study (DPS) nursing home 
questionnaire (NHQ) and knowledge and attitude (KA) -survey  
Phase II: Educational intervention  
Phase III: Post intervention DPS, NHQ, KA and evaluation 
 
The intervention study was the first major study, focusing on antibiotic use and 
methods for improvement in the institutionalised elderly, which included a wide variety 
of locations in Sweden. Interdisciplinary work and evaluation of the methods in the 
pilot study were measures taken to increase the use of the method outside the research 
setting as well as to increase the likelihood of sustainable changes. A time frame for 
SANT is presented in figure 12. 
 
 2002 2003 2004 2005 
 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 
Pilot                 
Baseline                 
Intervention                 
Post-interv                 
FGD                 
SANT                 
Baseline                 
Intervention                 
Post-interv                 
Figure 12. Time frame for when the different phases were conducted in the Swedish Antibiotic Nursing 
home Trial – SANT. 
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3.2 STUDY DESIGN 
A summary of study designs that has been used in the four different papers that this 
thesis is based on is presented in table 5. 
 
Table 5. Summary of main study designs used 
 
 Paper I Paper II Paper III Paper IV 
Study designs 
used 
Cross-sectional Cross-sectional Mixed methods  
Focus group 
discussions and 
Cross-sectional  
Randomised 
controlled trial, 
RCT 
 
Cross-sectional studies, which are the chosen design for paper I and II are observational 
studies i.e the researcher only measures what is there, without intervening. The 
advantages are that they are simple and cheap in comparison to more complex 
experimental design and they provide individual data, which ecological studies with 
aggregated data are unable to offer.  
 
A mixed methods design was chosen for Paper III. Mixed methods research has been 
defined by Tashakkori and Creswell 2007, as “research in which the investigator 
collects and analyses data, integrates the findings, and draws inferences using both 
qualitative and quantitative approaches or methods in a single study or a program of 
inquiry” [99]. The use of mixed methods has been the cause of some debate in social 
science. According to Onwuegbuzie and Teddlie, 2003 there can be advantages to 
combining methods at a chosen level [100]. The presentation of mixed methods can be 
challenging, but Östlund et al. 2011 is of the opinion that mixed methods and 
triangulation is also helpful within nursing and health care sciences to clarify, 
understand, and draw valid conclusions from the result [101]. 
 
The rationale for choosing focus group discussions was mainly based on the objective 
of Paper III. Focus groups provide the unique opportunity to capture interaction 
between the participants [102, 103].  As we wanted to study shared experiences we 
chose homogenous groups i.e we divided the participants into groups comprising 
nursing assistants, nurses and general practitioners. EP was the facilitator at all focus 
group discussions. We used a semi-structured guide with exploratory probe questions 
to be used if the discussion faltered. The main items were “infections and the elderly”, 
“difficulties in treating UTI in the elderly”, “hygiene”, “management of infections – 
anything you wish to change in your nursing home?” and “advice for development of 
an education concerning infections”. The focus group discussions were tape-recorded 
and transcribed. The data was analysed using content analysis influenced by the five 
different stages in the framework model [104]. 1) Familiarisation was achieved by 
listening to the tapes, reading the whole transcripts and the observational notes several 
times and by making notes in the material 2) A thematic framework was identified by 
noting key issues and referring to the aims that were set at the beginning of the study 3) 
All the data was Indexed by noting parts with the same content in the margin 4) The 
step referred to as Charting was made by cutting, pasting and coloring the parts with 
similar content that was indexed in the previous stage from different FGDs. This part is 
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a form of decontextualisation. 5) In the last stage, mapping and interpretation the data 
was recontextualised and once again interpreted as a whole while keeping the aim in 
mind. The theme that emerged came from reading the transcripts interpretively over 
and over again and looking for an essence in the material [105]. 
 
The SANT-trial is a cluster randomised controlled intervention study with two study 
arms i.e intervention and control group. For guideline implementation studies, the 
cluster randomised controlled trial is considered to be the optimal design [74]. It has 
advantages such as lowering the risk of contamination in comparison with patient 
randomised controlled trials. However, the statistical power is reduced compared to a 
patient randomised trial of equivalent size [106]. The assumption of the data being 
independent is also altered in cluster randomised trials, so certain steps need to be taken 
in the planning and analysis of the study [107]. Patients, or in this case the targets of 
our intervention - nurses and physicians within one cluster - are more likely to respond 
in a similar manner to the intervention. This intracluster dependence is taken into 
consideration by calculating the ICC, Intracluster Correlation Coefficient or using 
estimates of ICC from the literature [106].  
3.3 STUDY POPULATION AND SETTING 
 
3.3.1 Outpatient study 
During one week in November 2000 five counties: Uppsala, Östergötland, Kronoberg, 
Dalarna and Jämtland participated in this prospective study where all patients with an 
infectious complaint were registered regardless of whether they were prescribed an 
antibiotic or not. The counties were selected to generate a geographic spread, and to 
include both high and low prescribing counties. The sales of antibacterials for systemic 
use in 1999 ranged from 12.7-16.5 DDD/TIND in the selected counties [27]. 155 
primary care centres (600 doctors), 24 hospital departments or specialised surgeries 
(ears, nose, throat - ENT, infectious diseases and paediatrics) and 20 individual private 
practitioners agreed to participate.  
 
3.3.2 Pilot study and SANT 
Inclusion criteria for participating nursing homes in the SANT-trial were nursing 
homes or special types of housing where the facilities included a common dining room 
and common health personnel. To reduce the number of drop-outs it was desirable that 
staff turnover was low and that the nursing home had a contact person available. 
Specialised nursing home/wards e.g. oncology wards were not included in the study. 
 
The pilot study took place in the county of Norrbotten and the subsequent phases in 
different parts of Sweden, see also table 6. 
 
All registered nurses charged with the medical responsibility for nursing homes in 
Sweden were invited (n=366, at the time of invitation) to participate in the study. Those 
who took an interest in the study forwarded the information to the nurses at the nursing 
homes in their area, who then decided whether or not to participate. Participation was 
voluntary and based on the participants’ willingness to co-operate. 
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3.3.2.1 Sample size for SANT 
The following assumptions have been made. At least 25% of the residents will have an 
infection during the three months of data collection, according to the pilot study (27-
34%). At least 90% (90-98%) of these will receive antibiotics. During the baseline of 
the pilot study, 4.9% of the residents received a quinolone. In another study there were 
4.7% quinolone users [46]. To cover both, the quinolone users were assumed to be 
between 4.5% and 5.5%. The intracluster correlation coefficient, ICC, was assumed to 
be 0.05. In another study similar to ours, the ICC was 0.04 [108].  Standard sample size 
calculations need to be inflated by a factor known as the design effect, Deff = 1 + (n – 
1) where n is the average cluster size and is an estimate of the ICC [109].   
 
The following figures were included in the power calculations: 
 ICC was given the conservative value of 0.05  
 Weighted average number of residents in each nursing home was 60 
 Deff, was calculated to 3.94 
 Level of significance was set to 0.05 
 Power: 80% and 90% respectively. 
 The least difference we wanted to be able to detect was 20% related to the use 
of quinolones in the control group. 
 
With 80% power we needed 863-1121 in each study arm (5.5% - 4.5% quinolone 
users) and with 90% power we needed 1159-1498 in each study arm. 
 
65 nursing homes were eligible for participation at the start of SANT. 
 
3.3.3 Focus group discussions 
The participants in the focus group discussions were recruited separately from the pilot 
study and SANT-trial. The participants were selected purposively to represent different 
categories of staff working in nursing homes i.e nursing assistants, nurses and GPs. As 
one purpose of the focus groups was to share and discuss about experiences of 
infections in the nursing home setting, the participants needed to have some own 
practical experience from working in nursing homes. The nursing assistants and nurses 
came from Norrbotten county and the general practitioners from Jönköping county. 
 
The study was conducted at the division of Global Health (IHCAR) at the Department 
of Public Health Sciences, Karolinska Institutet in collaboration with the hospital 
pharmacy in Sunderbyn. 
3.4 PHASE 0: PILOT STUDY AND FOCUS GROUP DISCUSSIONS 
The pilot nursing homes took part in a small-scale study, without a control group i.e a 
before and after study. Medical Responsible Nurses in two municipalities in Norrbotten 
county were contacted and informed about the project. Interested nursing homes were 
invited to participate in the pilot project. The aim of the pilot study was to: 
 Develop the instruments to be used in the SANT-trial (DPS, KA, NHQ, 
educational intervention and evaluation form) 
 Estimate data collection time needed for the diagnosis prescribing survey in 
order to achieve a sufficient number of observations.  
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 Test the questionnaires, which were used during the nursing home and 
knowledge and attitude survey, for feasibility and face validity. 
 Adjust the way of working in order to increase the feasibility. 
 
The focus group discussions have been used as a tool to understand the prescribing 
process of antibiotics and target the need for continuing education and explore barriers 
and facilitators for behavioural change. 
 
3.4.1 Development of the instruments for outcome measurements 
The instruments for outcome measurements were developed through several meetings 
and correspondence with other members of the research group. They were thereafter 
tested and discussed during the pilot study. The three main outcome instruments are 
described below. 
 
The form used for the DPS, was a modified version of the form used for studying 
antibiotic prescribing in out-patients [Paper I]. As the form had been used in another 
setting, the content of the questionnaire was modified to suite the infection pattern in 
the nursing home setting.  
 
The main content of the NHQ was resident and nursing home characteristics such as 
number, age, sex and functional status of the residents and human resources. Later on it 
also included questions concerning infection control routines and number of residents 
immunised against influenza. It gave us basic information about all the included 
nursing homes and was also to be used in comparison and explanation of the results 
between the different nursing homes. 
 
The KA-form was developed during project group meetings, mainly based on 
experience from the members in the project group and the literature. The focus was on 
treatment and management of UTI. It also contained fictitious cases of UTI. The 
fictitious cases are modified versions of the fictitious cases developed by IHCAR 
(Stålsby Lundborg C and Wahlström R) and Strama during the “Year of infection, 
2000” (for each year Apoteket AB, The National Corporation of Swedish Pharmacies, 
had a special theme). 
 
3.4.2 Changes in the instruments for outcome measurements 
Some changes in the questionnaires were made before the main trial. For the DPS 
questionnaire the indications for SSTI were extended and the indications for respiratory 
tract infections were reduced. Questions about earlier infections and use of antibiotics 
during the last three months were added. The question on where the antibiotics were 
retrieved from was excluded and the order of the questions was rearranged. In the pilot 
study the same KA-questionnaire was used for physicians and nurses. In the main study 
different questionnaires for physicians and nurses were used. The items concerning the 
choice of treatment were reduced in the nurses’ questionnaire. Before the main trial, the 
NHQ was extended to also include questions concerning hygiene and vaccination with 
influenza vaccine. 
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The questionnaires used in the main trial (DPS and KA have been translated from 
Swedish to English) can be found in Appendix II (DPS), III (NHQ), IV (KA 
physicians) and V (KA nurses). 
 
 
3.4.3 Outcome measurements 
The outcome measurements were set based on experiences from paper I, further 
analysis of data concerning the elderly of data collected for paper I, the pilot study and 
project group meetings.  
 
3.4.3.1 Primary outcome 
Proportion of quinolones prescribed for lower urinary tract infection, UTI, in women.  
 
3.4.3.2 Secondary outcomes  
For all infections 
i. proportion of recorded infections treated with an antibiotic 
ii. proportion of infections handled by “wait and see” by the physicians 
 
For lower UTI in women 
iii. proportion of nitrofurantoin 
 
3.4.4 Development of the intervention 
As a process evaluation tool or checklist to describe the intervention, the framework for 
describing the key features of a quality improvement intervention published by 
Hulscher et al. 2003, has been used [110]. To identify barriers and facilitators and to be 
able to tailor the intervention to the target group, we used: literature search, 
multidisciplinary project meetings, focus group discussions, baseline data and 
eventually also the experience acquired during the educational intervention in the pilot 
study. The focus group discussions were for feasibility reasons not fully analysed 
before the intervention. However, the facilitator for the focus group discussions and the 
intervention was the author of the thesis, and thus the experiences from the focus group 
discussions could be brought into the educational sessions. During the development of 
the intervention, several project meetings were held where the questionnaires and 
methods were discussed. The project group was multidisciplinary and had vast 
experience from the areas of infection, hygiene, statistics, social science, pharmacy, 
pharmacology, intervention studies and experience from working in nursing homes. In 
Appendix VI there is an overview of how the different parts of the thesis project 
contributed to the intervention. 
 
 
3.4.5 Description of the intervention 
 
3.4.5.1 Main components and content of the intervention 
Two parts of voluntary continuing medical education of 1.5 hours each. The facilitators 
were one pharmacist (EP), one physician and one hygiene nurse if available. The 
physician was an infectious disease specialist (sometimes the head of communicable 
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disease control in the county) or general practitioner with experience from Strama 
work. The facilitators presented the educational material. 
 
Part I consisted of results from the baseline data collection and local resistance and 
prescribing pattern was discussed. During this session the prescribers got feedback on 
their prescribing. 
 
Part II was a presentation of guidelines for treating UTI, pneumonia and skin- and soft 
tissue infections.  It also contained information about immunization against influenza 
and pneumococci. The facilitators encouraged a discussion on the presented 
information and introduced some important questions that we wanted to have addressed 
during the sessions. Routines for influenza vaccination and what had been done locally 
to increase the number of immunised residents, was for instance part of the presented 
material. A hygiene leaflet was distributed during the discussion on hygiene in the 
nursing homes. As a reminder from the education session, a verbal summary was made 
and a short written guideline for antibiotic prescribing was distributed at the end of part 
II.  
 
The educational material used, including references, cannot be found as an appendix to 
this thesis as it is in Swedish, but can be requested at no-cost from Eva Pettersson by 
sending an e-mail to eva.pettersson@ki.se or eva.e.pettersson@apoteketfarmaci.se 
Note that the guidelines have been changed. For example trimethoprim is no longer a 
first-line choice for treatment of lower UTI in women. 
 
3.4.5.2 Target group of the intervention 
Nurses and physicians (usually general practitioners, GPs) connected to the 
intervention nursing homes were invited to participate in the intervention.  
 
3.4.5.3 Main outcome measures 
See separate section 3.4.3 
 
3.4.5.4 Evaluation of the intervention 
After education part I and II respectively, a written evaluation was done using a 
questionnaire with a six-point Likert scale, Appendix VII.  
 
3.4.5.5 Guidelines 
The acknowledged guidelines for the study were mainly based on available national 
and/or regional recommendations and material at the time for the study from Strama, 
Swedish Medical Products Agency, Apoteket AB, Svenska infektionsläkarföreningen 
(Swedish Association for specialists in infectious diseases) and the local drug 
therapeutic committees. In Sweden at the time for the intervention, the recommended 
antibiotics for lower UTI in women were pivmecillinam, nitrofurantoin or a 
cephalosporin for 57 days, or trimethoprim for 35 days. For pneumonia, considering 
the aetiology, penicillin V should have been the most prescribed antibiotic followed by 
amoxicillin. 
 
 30 
3.4.5.6 Barriers and facilitators for changing professional behaviour 
Obvious factors that could affect the study results negatively were if the participants 
found it too time consuming to fill in the registration form or if too few were exposed 
to the intervention. This was already being taken into careful consideration at the 
planning stage of the study. The form used for the DPS in the SANT-trial had been 
used earlier in registration of infections in outpatients, where it had already been 
evaluated [Paper I]. However, as it was modified for this patient group and setting, we 
needed to re-evaluate it in the pilot study.  
 
Identified barriers and facilitators to change that were applicable in our study were: 
- Knowledge about guidelines 
- Attitudes toward the specific guidelines and guidelines in general 
- Social factors, such as opinion leaders and colleagues at the nursing home/health 
care centre 
- Organisational factors including availability of guidelines at workplace and 
availability of antibiotics.  
- Structural factors such as location and building. 
- Economic factors such as lack of resources (time, personnel). 
 
The intervention mainly addressed the first four barriers/facilitators. The study design 
took economic factors into account, to the extent that the forms used were simple and 
quick to complete and the intervention was offered several times so that staffing 
issues could be solved. However no part of the intervention in itself dealt with 
economic factors. 
3.5 PHASE I: BASELINE STUDY, DIAGNOSIS-PRESCRIBING STUDY 
The baseline data collection was conducted during three months from the 15th of 
September 2003 to the 15th of December 2003. Baseline data collection consisted of 
three parts: a diagnosis-prescribing survey (DPS), a nursing home questionnaire (NHQ) 
and a knowledge and attitude survey (KA), see Appendix II, III, IV and V. 
 
For the DPS, Appendix II, the responsible nurse was requested to fill in a form for all 
patients with infectious symptoms which required a physician’s opinion. Recorded 
information included patient data, duration of symptoms, and kind of contact with 
physician (direct or indirect contact), the main diagnosis, diagnostics, treatment with 
antibiotics, referral or both, type of antibiotic and treatment length and factors 
influencing the choice of treatment. The form is a slightly modified version of the one 
previously used in the outpatient study in Paper I. 
 
The NHQ, Appendix III, was used to collect information about the nursing homes, such 
as human resources (recalculated as full-time employees), availability of doctors 
(number of hours per week) infection control routines, age and gender of the residents, 
number of residents immunised against influenza, functional status of the residents etc. 
 
A knowledge and attitudes (KA) questionnaire was sent to participating physicians, 
Appendix IV and nurses, Appendix V. It included questions on management and 
treatment of UTI and also fictitious UTI cases.  
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3.6 RANDOM ASSIGNMENT 
After the collection of baseline data (phase I) the nursing homes were randomly 
assigned (i.e randomisation was done at nursing home level) to control or intervention. 
As one of the aims of the intervention was to decrease the number of diagnosed 
UTI/residents, we decided to stratify the material into 3 equally sized groups based on 
number of UTI/residents for each nursing home. To get a geographic spread of the 
intervention and control, the nursing homes were also divided into north, central and 
south Sweden (there are 3 defined regions called Norrland, Svealand and Götaland). 
The nursing homes within each of the nine final strata were randomly allocated to 
either intervention or control. This was done in SPSS. As the material was small, 9 
different files were created in SPSS and then 50 % were selected randomly, with those 
selected belonging to the intervention group. For number of nursing homes in each 
study arm in the different counties, see table 6. 
 
Table 6. Nursing homes in each study arm in the different counties. 
 
County 
 
Intervention Control 
Norrbotten 1 4 
Västernorrland 1 0 
Jämtland 3 2 
Gävleborg 3 1 
Dalarna 5 1 
Värmland  3 4 
Västmanland 4 3 
Stockholm 2 6 
Södermanland 1 0 
Örebro 0 1 
Jönköping 0 1 
Västra Götaland 0 1 
Kalmar 2 2 
Kronoberg 0 1 
Skåne 4 2 
Total 29 29 
 
3.7 PHASE II: EDUCATIONAL INTERVENTION 
The nursing homes in the intervention arm received the educational intervention from 
the 25th of October 2004 to the 21st of January 2005. Although it was considered that 
the peer group had considerable knowledge, we chose to have external facilitators 
during the educational sessions in order to take the discussions further and to introduce 
new material. A pharmacist together with a physician and a hygiene nurse were 
facilitators during the educational sessions. There were two sessions of approximately 
1.5 hours each. An essential element was feedback on baseline results (phase I) and 
group discussions around them in relation to treatment recommendations, focusing on 
the major infectious disease areas, UTIs, pneumonia, and skin and soft tissue infections. 
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In addition to feedback and references to available guidelines, barriers to change such 
as structural, organisational and social factors were discussed. In order to standardise 
the intervention, material for presentation was developed and produced in the study 
group. The pharmacist i.e the author of the thesis was the same for all educational 
sessions. However, as we believed that a sustainable change would be more likely if we 
tailored the intervention for the different nursing homes, the participating physician and 
hygiene nurse were local and we referred to guidelines from respective drug therapeutic 
committee.  
 
3.8 PHASE III: POST INTERVENTION DIAGNOSIS-PRESCRIBING STUDY 
AND EVALUATION 
The post intervention data collection was undertaken from the 14th of February 2005 to 
the 16th of May 2005. Phase I, i.e. DPS, NHQ and KA were repeated for the nursing 
homes and the results were compared with the baseline results. As seasonal variations 
of infections (based on sales statistics) are small in this patient group, the months for 
the data collection were selected for practical reasons rather than in consideration of the 
infectious disease panorama (figure 11).  
 
The intervention was evaluated and the feasibility of the method was assessed both by 
looking at the results from the post-intervention data and by questionnaires distributed 
to participating doctors and nurses. Appreciation was evaluated by a modified version 
of a questionnaire used earlier, Appendix VII [111].  
 
Traditionally cluster randomised studies have used the cluster as a unit of analysis with 
only one aggregated data point per cluster. However, by using more complex 
approaches such as regression analysis or hierarchical models, patient level data may 
also be taken into account. Such approaches have been used previously [112].  
 
3.9 DATA ANALYSIS AND STATISTICS 
See also sample size calculations, section 3.3.2.1. The software SPSS version 10.0 to 
17.0 was used in the analysis of the quantitative data. For precision of measurements, 
the 95% confidence interval, CI, for proportions has been calculated. For, lower UTI in 
women, the major indication for antibiotics, the choice of antibiotics and duration of 
treatment was also assessed in relation to the recommendations. All figures describing 
the intervention effect have been adjusted for the design effect. After the intervention 
the ICC and the design effect was calculated for each outcome variable. For the 
primary outcome proportion of quinolones for lower UTI in women, the calculated ICC 
was 0.03. Deff = 1 + (n – 1)where is the estimate of ICC [109]. All standard errors 
for calculating the confidence intervals were adjusted for the design effect. To explore 
potential confounders a multivariable linear regression was performed in SPSS 17.0. 
The potential confounders explored were: residents’ age, availability of physicians, 
nurses and nursing assistants, IUC, volume of disinfection alcohol consumed and 
special needs of the residents. The special needs of the residents were calculated as 1/7 
x Hygprop + 1/7 x Clothprop + 1/7 x Movprop + 1/7 x Toiprop + 1/7 x Eatprop + 1/7 x Pressprop + 
1/7 x LegProp. Hygprop is the proportion of residents not managing personal hygiene. 
Clothprop is the proportion of residents not managing clothing. Movprop is the proportion 
of residents not managing moving around. Toiprop is the proportion of residents not 
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managing visits to the toilet. Eatprop is the proportion of residents not managing eating. 
Pressprop is the proportion of residents at the nursing home with pressure wounds. 
LegProp is the proportion of residents at the nursing home with leg ulcerations. The 
choice of items in the special needs formula was influenced by Katz ADL-score. We 
chose to dichotomise the variables to either dependent or independent [113] 
 
3.10 ETHICAL CONSIDERATIONS 
Prior to the initiation of the project, ethical approval from the Ethics committee at the 
Karolinska Institutet and from local ethics committees was applied for and granted. 
Approval from the Ethical Committee in Umeå for the pilot study, (dnr 02-330) and 
approval from the Ethical Committee at Karolinska Institutet for the main study 
(including the focus groups, dnr 03-070) and for the analysis of diagnosis/prescribing 
data (dnr 03-280).  
 
The head of all units involved in the project as well as involved physicians and nurses 
were asked to give their written informed consent. 
 
The participation was voluntary i.e. only nursing homes where the doctors and nurses 
agreed to participate were included. The control nursing homes were also invited to an 
educational session, including feedback on data, after the post-intervention data 
collection. 
 
4 RESULTS 
4.1 THE PILOT STUDY 
Seven nursing homes in two municipalities in Norrbotten county with a total of 472 
residents (range 48-93, mean 67) and an average age of 84 years, were enrolled in the 
pilot study. 
 
The results from the KA-questionnaire have mainly been used to target problem areas 
to be discussed during the intervention. Some lack of knowledge, or problem areas 
could be seen in diagnostics, symptoms of infection, IUC, when to initiate antibiotic 
treatment, duration of treatment, choice of treatment and gender differences in 
treatment. The results from the KA-questionnaire revealed a quite positive attitude 
towards quinolones whereas nitrofurantoin had a bad reputation for treatment in the 
elderly. 
 
During the baseline of the pilot study, 4.9% of the residents received a quinolone. 
This figure was used in the sample size calculation for SANT (3.3.2.1).  
 
From the DPS it was found that the average age of residents with an infection was 85 
years. An overall decrease in total number of infections could be seen after the 
intervention – from 162 to 122. However, the number of infections related to the 
number of residents during the three-month data-collection at the different nursing 
homes ranged from 0.23-0.46 pre and 0.12-0.40 post intervention. At baseline, 90% 
were treated with antibiotics and post intervention this figure was 98%. The most 
common infection was UTI, in particular lower UTI, followed by skin- and soft tissue 
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infections and respiratory tract infections, RTI, where pneumonia was the dominating 
diagnosis. The proportion of short term regimens (5 days) increased from 3% to 
25% after the intervention. In 52% pre and in 78 % post intervention in the pilot 
study, the antibiotics were retrieved from the medical supply room at the nursing 
homes and not by prescription.  
 
The questionnaires were tested for face validity. 
 
4.2 PAPER I 
Paper I provided information about treatment of infections in outpatients. 7,029 of the 
7,071 forms returned, included information on diagnosis; infections of the respiratory 
tract, urinary tract and the skin or soft tissues were responsible for 70%, 14% and 10% 
of the visits. In 59% of all cases antibiotics were prescribed. PcV was the most 
commonly prescribed antibiotic. Quinolones were used in 21% of females where a 
lower UTI was reported as the indication for antibiotics, where it is not the 
recommended choice of treatment. In conclusion, this study provided information on 
the treatment pattern associated with various infections. 
 
The data collected for Paper I was further analysed comparing the elderly  65 with the 
group 16-64 years (unpublished results) and we found a significantly higher frequency 
of UTI, recurrent UTI and upper UTI in the elderly, and low prescribing of 
nitrofurantoin to the elderly. From this knowledge about infections in outpatients, the 
focus was directed towards the nursing homes, where it was known that UTI is a 
common infection [46-50]. UTI was to a large extent treated with quinolones in 
outpatients and we thus expected to find problem areas of antibiotic prescribing in the 
nursing homes. 
 
4.3 PAPER II 
This cross-sectional study based on data from baseline measurements in the SANT-trial 
provided us with information about the treatment pattern of infections in the nursing 
home setting. As expected a high proportion of the 889 registered infections were 
treated with antibiotics – 84%. The physician was often not present at the nursing 
home, but prescribed antibiotics on second hand information from the nurses e.g. by 
phone in 38% of the cases. The indication for antibiotics was in more than half of the 
cases an UTI. Treatment was in many cases not according to the guidelines. For 
example women with lower UTI received treatment which, in half of the cases, was not 
in line with the recommendations. The main concerns that we needed to focus on in the 
intervention were the high use of quinolones and the length of treatment. For 
pneumonia, the use of doxycycline needed to be discussed. The results from Paper II 
also supported the inclusion of both physicians and nurses in the educational 
intervention due to the high proportion of antibiotics reported to be prescribed without 
the physician being present at the nursing home.  
 
4.4 PAPER III 
The theme that emerged was: “Interpersonal relations, timing and setting – the main 
determinants for management of UTIs and antibiotic prescribing in nursing homes.” The 
focus group discussions provided a deeper understanding of the interplay between the 
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staff at the nursing homes and how it affects different important aspects in the 
prescribing process of antibiotics. The categories that appeared during the analysis 
were:  
 Symptoms of urinary tract infections – clinical signs and attitudes 
 What leads to antibiotic prescribing? 
 What does a positive dipstick or positive urine culture mean? 
 Communication between staff concerning infectious symptoms 
 Hygiene in the nursing home setting  
 
Although not included in the results section of paper III, one of the most important 
contributions concerning barriers and facilitators for behavioural change, which could 
not be elucidated from the pilot study, was the discussions and examples given on 
communication in the nursing homes. The praxis for communication seemed to differ 
between the nursing homes due to the people involved in the process. Another 
important input from the focus groups discussions regarding barriers and facilitators, 
was the addition of the nursing assistants’ perspective. The structural and organisational 
barriers, especially difficulties of complying with hygiene guidelines were described 
both with examples of the different tasks of the nursing assistants and also availability 
of correct work wear such as disposable aprons and gloves. 
 
4.5 PAPER IV 
46 of the included 58 nursing homes completed the study. Pre and post-intervention, 
702 and 540 infectious episodes respectively, were recorded. The effect on the primary 
outcome, proportion of quinolones prescribed for lower UTI in women, was not 
signficant 0.028 (95% CI -0.193 to 0.249). However, the proportion of infections 
treated with an antibiotic, decreased significantly in the intervention group, by -0.124 
(95% CI -0.228 to -0.019), in comparison with the control group. The proportion of 
infections handled by physicians’ “wait and see” policy, increased in the intervention 
group by 0.143 (95%CI 0.047 to 0.240) in comparison with the control group. We 
could not attribute an effect to the intervention on any of the other outcomes. 
 
Both the intervention and the control group increased their adherence to the guidelines 
concerning the selection of antibiotics by 0.222 (95%CI 0.115 to 0.329) and 0.225 
(95%CI 0.090 to 0.359) (not published results). 
 
Out of the participants 164 were exposed to the educational intervention according to 
the attendance lists of which 13 were general practitioners. 165 nurses and 41 
physicians at the nursing homes had given their written informed consent to participate 
in the trial. 105 filled in the evaluation form, of which nine were general practitioners. 
The educational intervention was appreciated by the participants. They considered that 
it was well worth the time, and appreciated both the content and form of the education 
and the facilitators for the intervention, Appendix VIII. 
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5 DISCUSSION 
The studies included in this thesis have provided us with information on infections and 
treatment with antibiotics in outpatients (Paper I) and the elderly living in nursing 
homes (Paper II-IV and the pilot study). They have also contributed to the development 
of an educational intervention for the most common infections in elderly residents in 
nursing homes (Paper I-III and the pilot study). The intervention has been evaluated in 
terms of changes in antibiotic treatment, adherence to guidelines for lower UTI in 
women and appreciation by the participants (Paper IV). A summary of the main results:  
 
 In the outpatient setting 59% of patients with infectious complaints were treated 
with antibiotics (Paper I). In nursing homes the corresponding figure was 84% 
(PaperII). 
 Women with lower UTI were treated with a quinolone in 21% of the cases in 
the outpatient settings (Paper I) and in nursing homes 29% (Paper II). 
 In 38% of the cases in nursing homes, the prescriptions of antibiotics were 
issued during an indirect contact with the physician i.e by phone, fax or e-mail. 
 Half of the women with lower UTI in nursing homes, received a treatment 
which was not in line with the recommendations (Paper II). 
 The focus group discussions (Paper III) have provided us with the perspective 
on the staffs’ own experiences of infections in nursing homes. They have also 
increased our knowledge on barriers and facilitators to behavioural change 
within the process of antibiotic prescribing.  
 The educational intervention had a modest effect on most outcome variables, 
including the primary outcome, but reduced the proportion of infections treated 
with an antibiotic by 12% (Paper IV).  
 The participants of the intervention considered that it was well worth the time, 
and appreciated both the content and form of the education and the facilitators 
for the intervention (Appendix VIII). 
 
5.1 RESULTS DISCUSSION 
Pilot studies are seldom published, but they are important as they can improve the 
chances of success in the main trial [114]. The pilot study provided a feasible method 
for developing an educational intervention and evaluating the prescribing pattern of 
antibiotics in nursing homes for the elderly. No nursing homes dropped out during the 
two-year study period, and the education sessions were appreciated by the participating 
physicians and nurses. The study was undertaken at a reasonable cost and effort to the 
participants.  
 
The outpatient study, Paper I, shows that the prescribing pattern is seemingly in good 
accordance with the recommendations, with a high use of PcV for RTI and PcV or 
isoxazolylpenicillins for SSTI. For lower UTI in women there was surprisingly high 
prescribing of quinolones. 
 
The results from Paper I and II informed us about some of the differences between the 
outpatient setting and the nursing home setting, in treatment with antibiotics. A higher 
proportion being treated with antibiotics in the nursing homes was expected due to the 
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pattern of diagnoses. UTI, SSTI and pneumonia in outpatients, also had a high level of 
treatment with antibiotics (87%, 74% and 89% respectively). Moreover, there is 
another explanation for the differences - the inclusion criteria for the DPS in SANT - as 
we registered those with an infectious symptom that required a physicians’ opinion. In 
the nursing home the nurse acts as a gate keeper before a contact with the physician is 
made, which means that simple infections managed by the nurses were not included in 
the results of Paper II. 
 
It may be questionable that the physician was not present in the nursing homes when 
38% of the antibiotics were prescribed, but as long as there is a nurse with competence 
and skills in dealing with the most common infections in the elderly, the physicians 
would often not be any wiser by physically visiting the nursing home resident if you 
consider for example the main diagnosis-lower UTI. However, it is important for the 
managers of the nursing homes to keep this in mind when they plan the nurses’ 
professional development. In the More and Romsdal prescription study for outpatients 
in Norway, by Rokstad and Straand 1997, the corresponding figure was 25% [115]. 
 
The indications for antibiotic treatment are generally in accordance with other studies, 
both in outpatients, where RTI are the most common indication [116-118] and in 
nursing homes with UTI as the main indication for antibiotics [46, 47, 67, 119-120]. 
However a point-prevalence study in the county of Västra Götaland 2004 had SSTI as a 
more common indication for antibiotics, 36%, but as the authors pointed out this could 
be explained by long-term treatments for chronic ulcers which can lead to a higher 
proportion of patients on antibiotic treatment in a point-prevalence study compared to 
an incidence study [66]. The prescribing of quinolones for UTI was higher in our 
nursing homes, 34%, than in other studies in Sweden where it has ranged from 21% to 
26% [46, 47, 66]. Bredmose-Hansen et al. 2002, presented the results in four different 
municipalities where the proportion of quinolones for UTI ranged from 15.4% to 
42.6% [47]. The diagnosis-prescribing survey done in 2000 (Paper I) was repeated in 
2002 and 2005. The results are quite similar between the years, but there has been a 
decline in antibiotic prescription for RTI, however no change for UTI and SSTI was 
noted. For lower UTI, the prescribing of pivmecillinam had increased while 
trimethoprim had decreased significantly between 2002 and 2005. There was no 
significant change in the prescribing of quinolones for lower UTI. The relative 
prescribing of nitrofurantoin had increased significantly from 2000 to 2002 and with a 
further, but not significant, increase in 2005 [30]. 
 
The focus group discussions (Paper III) made it clear that the nurses have a key role in 
the antibiotic prescribing process in the nursing homes, which is also supported in 
Walker et al. 2000 [121]. The shared experiences on infections, antibiotic treatment and 
possible barriers and facilitators for change provided by the participants in the focus 
group discussions, were very valuable in the planning of the intervention. The 
management of infections seems to be highly dependent on the characteristics of the 
people involved in the process. The focus group discussions also put words to the 
subtle symptoms interpreted as UTI in the elderly, that can trigger ordering of cultures 
and prescribing of antibiotics. Juthani-Metha et al. 2009, described the clinical 
presentations associated with positive urine culture, and found that dysuria, change in 
character of urine, and change in mental status were significantly associated with the 
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combined outcome of bacteriuria and pyuria. It also showed that almost two-thirds of 
the clinically suspected UTIs had a negative urine culture, which points out the risk of 
overdiagnosing UTI within this population [39]. The summary of what Walker et al. 
2000 refer to as “issues and themes”: Nurses’ and physicians’ interpretation of 
bacteriuria as “symptomatic” in the presence of nonspecific symptoms; the ordering of 
urine cultures for nonspecific changes in a resident’s status, the central role of the nurse 
in communicating nonspecific changes in the health status of a resident to physicians 
and family members; the difficulty in eliciting information about symptoms from frail 
elderly residents; uncertainty of physicians about the significance and management of a 
positive urine culture result; concern over liability of nurses and physicians [121] 
reminds us in many ways about the categories that emerged from our focus group 
discussions: Symptoms of urinary tract infections - clinical signs and attitudes; What 
leads to antibiotic prescribing?; What does a positive dipstick or positive urine culture 
mean?; Communication between the staff concerning infectious symptoms; Hygiene in 
the nursing home setting. The results are quite similar despite the fact that narrower 
objectives were presented to the participants before the sessions that the discussions 
would be about ordering of urine cultures and the prescribing of antibiotics for 
asymptomatic bacteriuria. This could indicate that it is not important, perhaps not even 
advisable, to be too focused in focus group discussions when your aim is to explore 
something. If the subject is relevant to the participants, they will narrow it down 
themselves to what they think is the most significant part of the discussion. In that way 
you minimise the risk of contaminating the discussion with your own preconceptions. 
 
In Paper IV, the statistically significant result of lowering the total prescribing of 
antibiotics was unexpected as Sweden is a low-prescribing country with respect to 
antibiotics [26]. Some would argue that lowering antibiotic prescribing with 12% is not 
a modest effect, especially if you could achieve a 12% sustainable decrease on a global 
basis. It is an average effect compared to other interventions targeting antibiotic 
treatment [97]. There was indeed an improvement of adherence to the guidelines during 
the post-intervention DPS, in comparison to the baseline DPS. The use of 
recommended antibiotics for lower UTI had increased and the prescribing of 
quinolones was lower after the intervention. However, these results could not be 
attributed to the intervention, as the change was similar in the control group. This could 
indicate that another intervention rather than ours had influenced the prescribing pattern 
of antibiotics. There is no specific intervention that we know of other than what is 
already mentioned in the paper i.e the active Strama work that seems to have had an 
impact on the prescribing behaviour in Sweden during the time of our study [122]. The 
reduction in UTI was lower in the intervention group than in the control group. We do 
not know the reasons for that, but it could be attributed to the lower antibiotic usage 
causing recurrence of infections. However, if that was the case, those infections should 
have been recorded as recurrent UTI in the form and we could not see any difference 
between the groups concerning recurrent UTI. 
 
5.2 METHODOLOGICAL CONSIDERATIONS 
 
For cross-sectional studies (Paper I and II) it is crucial to have a representative sample 
if generalisations of the results are to have any validity. In paper I there are some 
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problems that we can mention: The included prescriber categories only represents 70-
75% of the prescriptions of antibiotics; the number of forms returned per 1000 
inhabitants ranged from 3.73 to 7.68 for the 5 counties; and the actual response rate is 
difficult to assess. It could give a skew picture of the diagnosis and treatment pattern if 
the responses were elective in their nature e.g. if only those physicians that already 
comply with the guidelines are the ones responding or if they only include the patients 
when they know a prescription of antibiotics was justified.  If the response rate is high, 
the problem with physicians randomly choosing not to respond in the survey would be 
a minor one. Today we have data from repeated similar surveys made in 2002 and 
2005. Those surveys have not provided any unexpected results that give us reason to 
question the validity [30]. As the result from this study is also consistent with other 
similar studies it is fair to conclude that the sample was reasonably representative [116-
118].  
 
The cross-sectional study in Paper II also deals with some difficulties due to 
representativeness and response rate. The prescribing of antibiotics was a little bit lower 
than earlier studies [46, 47, 67] which could indicate that our sample of nursing homes 
has a greater interest within the area of infections and antibiotic prescribing and thus 
are already more compliant with guidelines than average nursing homes. The 
documentation of the forms was made by the nurses, which raises the issue of reporting 
bias. This was at first a balance between getting a high response rate and validity of the 
information provided in the forms. But looking at studies in other fields, such as 
reporting of adverse events - there could be advantages involving the nurses in 
reporting, both to increase reporting rates [123] but also in terms of increased validity 
[124]. The validity of the diagnoses could be questioned, as there was no clear 
definition, or a second opinion from a specialist within infectious diseases or a second 
opinion from a peer. However, our objective was not to study this under ideal 
conditions, but to get information about the real world scenario in the nursing homes. 
 
The use of mixed methods in paper III added more strength to the results than if the 
focus group discussions alone had been presented. The results indicate that the use of 
different methods can yield different results. For example, if we should have settled for 
the KA-questionnaire, we would not have had anything indicating the importance of the 
nurses in the prescribing process of antibiotics, which can be illustrated with the quote 
from one of the GPs participating: “I believe that a nurse who wants the patient to get a 
treatment, achieves this by describing (the symptoms/health status) in a certain way. I am 
totally convinced. This is part of the interplay we have – nothing strange about that, really.” 
 
The strength of focus group discussions (Paper III) is mainly in that it enables 
interaction between the participants [103, 125]. There are different orientations within 
this field of qualitative research, and Freeman 2006, means that the different and 
sometimes contradicting advice on ‘best practice’ when conducting focus group 
discussion, originates from the researcher’s epistemological perspective – realist or 
constructivist [102]. Mays and Pope 2000, also describes how relativists and subtle 
realists differ in their views on how to assess quality in qualitative research [126], 
which is also discussed in the review of Rolfe 2006 [127].  Choosing homogenic or 
heterogenic groups; pre-existing groups or not, mainly depends on the objective and the 
nature of the topic of the focus group discussion. Krueger 1993, supports homogenous 
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groups, although he states that it is important to vary group composition and use several 
sub-groups, as this makes analysis of group differences easier and increases the 
transferability of the results. He means that heterogeneity in the groups is contrary to 
the basic point of conducting focus groups i.e making people feel free to share their 
perceptions and thoughts [125]. Kitzinger 1994, believes that working with pre-existing 
groups captures “social contexts within which ideas are formed and decisions made” 
[128]. There is a rationale to choosing pre-existing groups for discussions on sensitive 
topics, to make the participants more comfortable sharing their thoughts. We chose 
homogenous groups, not to enable an analysis of the difference between the groups, 
but to increase the possibilities of the participants sharing their thoughts and 
experiences. The hierarchy between the groups in our study could have posed a 
problem if we had used heterogenic groups [125]. The focus groups in Walker et al. 
2000, were also homogenous, but they did not include nursing assistants [121]. The 
nursing assistants’ experiences were important in our study as we needed knowledge 
about the whole antibiotic prescribing process from the nursing assistant to the 
formally prescribing general practitioner. One might then ask why we did not involve 
the residents or relatives to these focus group sessions. It would certainly have added 
another perspective to these discussions. However, our main interest and objective 
was in the professionals’ interplay and communication. Reflexivity means sensitivity 
to how the researcher’s preconceptions and experiences and the research process have 
influenced the collected data [126]. In our focus groups my experience from working in 
nursing homes and my professional background as a pharmacist cannot be ignored, but 
two of the co-authors: one research nurse and one social anthropologist, have read the 
full transcripts and the research nurse also analysed the data. Some researchers use 
respondent validation or ‘member checking’ as they believe it increases the credibility, 
which is debated in the reviews by Mays and Pope 2000 and Rolfe 2006 [126, 127]. 
 
Paper IV. As we wanted to know whether the intervention was effective in the real 
world, we chose a pragmatic approach. Cluster randomised controlled trial for 
evaluating an educational intervention is the golden standard, but the pragmatic 
approach created some difficulties in the conduction and analysis of the trial which are 
described below. 
 
The modest effect of the intervention could be explained by several factors: i) low 
exposure or wrong participants in the intervention ii) a low agreement with the 
guidelines used iii) factors other than the intervention affecting our results. 
 
i) The evaluation showed a low participation by the physicians in the intervention, 
which could partly explain the modest effect of the intervention. But achieving this 
result without the physicians taking an active part in the intervention further provided 
us with information about the nurses’ key role in antibiotic prescribing in the nursing 
home setting. There were two control homes taking part of the intervention as the staff 
at these control homes had heard from staff at the intervention homes that an education 
would take place. This also points out the risk of contamination by staff working in 
different nursing homes in the same municipality, which would dilute the intervention 
effect. 
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ii) The modest effect could also be due to a low agreement with the guidelines used, 
which is rather unlikely as both the control group and the intervention group increased 
their adherence to the guidelines concerning the selection of antibiotics after the 
intervention. 
 
iii) Other factors that might have influenced our results are secular trends such as the 
decrease in prescriptions of quinolones per 1000 inhabitants and day by 14% from 2003 
to 2005 [122].  This was probably a result from general efforts made by drug 
therapeutic committees and local Strama-groups to increase adherence to treatment 
guidelines. Hawthorne effect is the effect that people tend to perform better when they 
know that they are being observed. As the intervention homes received more attention 
as they received the intervention there is a risk that they would report better compliance 
with the guidelines simply because they knew what we were studying. Actual 
performance was not studied. Due to feasibility, the time frame between the data 
collection and the intervention was long and varied between the nursing homes, which 
could have had an impact on the results. Many things happen during one year in a 
nursing home. The residents are different; staff could be different which means that 
those exposed to the intervention might not even work in the nursing home during the 
follow-up period. This was taken into consideration in the planning stage of the trial, as 
one inclusion criterion was a self-assessed stable staff situation. This could however 
change over time. The baseline data collection and the post-intervention data collection 
were conducted at different times of the year which raises the issue of seasonality. 
However, examining antibiotic prescribing in this age group shows that seasonality 
does not apply in a meaningful way, especially not to urinary tract infections in this 
patient group. 
 
Selection bias refers to systematic differences between comparison groups. Random 
allocation protects from selection bias. The level of randomisation is a trade off 
between the risk of contamination and the number of clusters available. A small 
number of clusters may lead to chance imbalances between the randomised groups on 
individual factors such as baseline performance or characteristics of the clusters, which 
may influence the observed intervention effect. Stratification before randomisation on 
important variables, in our study number of UTI/residents and geographical regions, 
was a measure taken to prevent selection bias. Selection bias is also used to describe 
systematic differences between those who have been selected to participate in a study 
and those who were not selected. The relatively low antibiotic prescribing in our trial of 
1.0 prescription per resident and year, indicates a risk of selection bias towards 
inclusion of nursing homes with less consumption of antibiotics and possibly more 
compliant with the guidelines to start with. As the situation was the same in the 
intervention and the control group at baseline this would not be a problem for the 
internal validity of the evaluation of the intervention effect unless the dropouts deviated 
from the average nursing homes (see attrition bias below). However, it could still cause 
problems for the external validity, generalisability, of the results. For example, the 
readiness to change stage could be different between nursing homes with a high 
prescribing of antibiotics compared to nursing homes with a low prescribing. These 
nursing homes would then respond in different ways to the intervention depending on 
their readiness to change according to the Prochaska’s stages of change model [77, 78]. 
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46 of the about 2600 nursing homes in Sweden participated in the whole trial and the 
results should be generalisable at least to low-prescribing nursing homes. 
 
An intention to treat analysis, ITT, is the golden standard for analysing clinical trials 
because it reduces the risk of overestimating the effect on an intervention [129]. An 
ITT analysis was performed with respect to allocation, but because full outcome data 
was not available for all randomised nursing homes, we had to do the analysis for the 
46 nursing homes remaining at follow-up, which is referred to as an available case 
analysis. How the dropouts have affected the results needed to be estimated as this 
analysis threatened the internal validity of the results.  
 
Attrition bias If those who drop out of a study systematically differs from those who 
remain, this attrition of the original sample poses a threat to both the internal and 
external validity in a study, which is usually referred to as attrition bias [130]. The 20% 
drop-out of nursing homes is potentially a problem, in particular the considerably 
higher drop-out in the control arm. An exploratory analysis showed that dropout 
nursing homes did not differ from those remaining in the trial based on the baseline 
outcomes, which indicates that attrition bias is unlikely to have affected our results. 
 
Type I error describes the error made if you reject the null hypothesis when it is in fact 
true i.e you find a difference between the groups in your sample, which does not exist 
in the population from which your sample was drawn. The primary outcome - 
quinolone use for women with lower UTI - did not differ between the arms, so the 
question on how much of the observed effect in the secondary outcomes that is related 
to type I error, arises. In clinical trials, significance levels are sometimes set lower for 
secondary outcome to avoid mass significance. If you perform k different tests each 
with a nominal significance level of  then: = P(Rejecting a given test | H0 for this 
test is true). The overall significance of the test procedure is, however, given by 
* = P(Rejecting at least one test | all H0 are true) and  * = 1-(1- )k. The probability 
of rejecting at least one test is thus greater than of rejecting a specific test. A 
significance level of 0.05 is common and for reasons of interpretation and comparison 
with other similar trials, the significance level for the secondary outcomes was also set 
to 0.05 although this means that the results on the secondary outcomes should be 
interpreted cautiously. 
 
ICC would have been high if management of patients within nursing homes was very 
consistent, but there was a wide variation in practice across nursing homes. An ICC of 
0.03 for the primary outcome is quite low, but still it makes the 95% CI wider. 
 
To follow trends and evaluate the sustainability of the effect of the intervention it 
would have been desirable to increase the frequency of measurements to at least three. 
The time and funding did not allow us to do this. This would also have required an 
increased effort from the participants and risk of a higher drop-out rate. 
 
Both from our experience and based on the literature, it is advisable to conduct a cluster 
randomised control trial to evaluate a multifaceted educational intervention, but the 
decline in quinolone prescriptions over time, clearly shows that the wrong primary 
outcome was chosen. 
   43 
 
The national efforts for containing antibiotic resistance and lower the levels of 
antibiotic prescribing are an ongoing struggle. The suggested long-term antibiotic goal 
from Strama and the Swedish Association of Local Authorities and Regions for the 
Swedish population, is 250 prescriptions per 1000 inhabitants and year [131]. The 
literature and this intervention study suggest that more drastic methods than educational 
interventions must be applied to reach this goal, such as legislative interventions or 
financial incentives for health care centers. However, variations between different 
counties in Sweden are high. In 2009 the prescribing rate ranged from 311 to 430 
prescriptions per 1000 inhabitants and year, which indicates that it should be possible 
for at least the high prescribing metropolitan areas to decrease the antibiotics to much 
lower levels.  
6 CLINICAL IMPLICATIONS 
Outpatients with an infectious complaint in the year 2000, would in more than half of 
the cases have received an antibiotic. If you were a woman with lower UTI in 2000, 
you would in two out of five cases have received a quinolone. If you were an older 
woman in 2003 with lower UTI living in a nursing home you would in one out of two 
cases not be treated according to the recommendations. In the worst case scenario you 
would have been prescribed a quinolone for too long a period of time, by a GP you had 
not met, for a diagnosis you might not have had to begin with. Prescribing of antibiotics 
is a complex process and in nursing homes interpersonal relations between the staff and 
also the resident or relatives seem to be important determinants for the outcome.  
 
In clinical practice the intervention effect would mean a reduction of approximately 6 
prescriptions of antibiotics during one year in a nursing home with 50 residents or 
about 12 020 prescriptions during one year for all residents in the Swedish nursing 
homes. 
7 CONCLUSIONS 
In outpatients, the prescribing pattern in general seems to be in accordance with the 
recommendations although some potential deviations could be discerned. 
 
The educational intervention influenced the prescribing as it reduced the proportion of 
prescribed courses of antibiotics and made the physicians handle a larger proportion of 
infections by ‘wait and see’. But as no intervention effect could be seen for the other 
outcomes including the primary outcome - proportion of quinolones prescribed for 
lower UTI in women - the intervention only had a modest effect.  
 
SANT included 46, at baseline 58, of about 2600 nursing homes in Sweden (2%). 
Education on infections and their treatment in nursing homes is continuously needed. 
Training should preferably include both physicians and nurses as a high proportion of 
antibiotics are issued without a direct contact with the physician. It is however essential 
for future educational interventions to understand the role of the nurses and physicians 
and their interplay in more detail for a successful intervention with a sustainable effect.  
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8 EPILOGUE 
The picture of antibiotic prescribing we have provided, is a picture with some 
problems. The most important of them was the high use of quinolones for lower UTI in 
women and the lack of evidence for choosing the right treatment regimen i.e the dose 
and the length of treatment for this patient group. When we came to the nursing homes, 
a picture of prescribing emerged where the physician, rarely present at the nursing 
homes, gets second hand information via reports from the nursing assistants and nurses. 
When should we treat and when not? Is there any evidence? Identifying the problems, 
creating the intervention, we found out that although we are country of low-prescribing 
in antibiotics, we could decrease the antibiotic use further and make the physicians 
more prone to ‘wait-and-see’. 
 
New guidelines for treatment of lower UTI in women were finally(!) developed during 
an expert meeting in 2006 at the medical products agency in Sweden. A number of the 
participants at that meeting have, in varied roles taken part in this project: Ingrid 
Brännström, Otto Cars, Sigvard Mölstad, Christer Norman and Nils Rodhe. So now it 
is time to conduct a new intervention study on compliance with the new guidelines, 
which should be easier as they are updated, evidence based guidelines. 
 
In 2008 and 2009, the guidelines for lower RTI and SSTI were also updated. 
 
I hope that the phrase “based on experience” will more often be combined with “based 
on evidence”. I am proud to have provided some of it. 
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Appendix II 
 
Nursing home: __________________________ Date:______________ 
A. General information 
1. Number of residents :  Men:  ____  Women: ____ 
  
2. Number of rooms/apartments: 
  
3. Average age:  Min/Max  ____  years to ____  years  
B. Special needs 
4. How many of the residents can manage by themselves: 
 Hygiene Clothing Movement Toilet Eating 
Number of residents      
C. Human resourses 
5. Man-labour year and time for GP’s round each week 
Nurses  
Assistants  
Nurses’ assistants  
Time for GP’s round per week (hours)  
D. Health care indicators 
6. Deviation handling 
Number of  deviations 
related to drugs 
Number of Adverse Drug 
Reactions 
  
 
7. Falling accidents during the last year 
Number of falling accidents Number of fractures 
  
 
NHQ Appendix III 
 
Nursing home: __________________________ Date:______________ 
 
8. How many of the residents…  
are given injectable drugs on a regular basis? 
have urinary catheter?   
have leg ulcer?   
have pressure ulcer?   
 
9. Have you had any outbreak of vomiting/diarrhoea in the nursing  
home during the last year?     Yes  No  
 
10. Do you have a written routine for seasonal influenza immunization?  Yes  No  
 
11. Proportion of residents immunized against influenza (%)?   
 
12. Can you do dipslide culture (e.g. Uricult) at the nursing home?  Yes  No  
 
13. Do you have written routines for diagnostic tests on suspicion of UTI?  Yes  No  
 
14. Do you have disinfection alcohol available at each:   Unit Yes  No  
     Floor Yes  No  
     Room Yes  No  
 
15. How much disinfection alcohol has been used during the last month?                          Litre 
 
16. Do you have written routines about: 
- Use of disinfection alcohol    Yes  No  
- Use of disposable gloves    Yes  No  
- Use of protection work wear (disposable apron/robes)?  Yes  No  
THANK YOU FOR YOUR PARTICIPATION! 
PLEASE KEEP THE COMPLETED FORM IN YOUR STUDY FILE 
Appendix III 
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Kunskaps/Attitydenkät för Urinvägsinfektioner vid särskilda 
boenden. Ifylld enkät sätts in i SANT-pärmen. 
Datum:   
Utbildning 
Läkare     Leg år 
Specialistkompetens   Nej 
       Ja, i så fall ange inom vilket område  
 
Anställningsform / anknytning till boendet 
Tillsvidareanställning     
Stafettläkare       
Vikariat        
Tillfälligt inkallad      
Annat        
 
Hur länge har Du haft kontakt med detta särskilda boende? 
          år 
 
Nedan finner du flera påståenden kring UVI. Ange för varje påstående om Du anser att 
det är sant eller falskt eller om Du inte vet om det är sant eller falskt. 
 
A. Symtombilden hos äldre 
 
1. Förvirring kan vara det enda symtomet hos äldre med UVI 
 
Sant   Falskt  Vet inte  
 
2. Vid UVI som kräver antibiotikabehandling är feber alltid ett symtom 
 
Sant   Falskt  Vet inte  
 
B. Diagnostik 
 
3. Om den boende har feber och symtom som tyder på UVI ska man göra en odling. 
Sant   Falskt  Vet inte  
 
4. Vid fynd av bakterier i urinen ska man alltid behandla. 
Sant   Falskt  Vet inte  
 
5. Falskt negativt nitrittest kan bero på följande: 
 
a. Kort blåsinkubationstid     Sant   Falskt  Vet inte 
b. Lågt bakterieantal i urinen   Sant   Falskt  Vet inte 
c. Intag av höga doser C-vitamin  Sant   Falskt  Vet inte 
d. Intag av järntabletter    Sant   Falskt  Vet inte 
e. Bakteriearten går ej att påvisa   Sant   Falskt  Vet inte 
 
KA physicians - 2 - 
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6. Falskt positivt nitrittest kan bero på följande: 
 
a. Vissa läkemedel     Sant   Falskt  Vet inte 
b. Fördröjd avläsningstid    Sant   Falskt  Vet inte 
 
i) Urin till nitrittestet bör tas från: (Rangordna även följande alternativ där 1 är det som är bäst) 
7.              ii) Rangordning 
 
a. Blöja     Ja    Nej  Vet inte    __ 
b. Kvällsurin    Ja    Nej  Vet inte    __ 
c. Morgonurin    Ja    Nej  Vet inte    __ 
 
ii) Urin från KAD, kvarkateter, ger tillförlitliga resultat på nitritstickan 
 
Sant   Falskt   Vet inte  
 
C. Behandling, generellt 
 
8. Om en patient får tillbaka en okomplicerad (nedre) UVI inom två månader efter första episoden, 
bör läkaren välja ett annat preparat än han/hon gjorde första gången pga risken för 
resistensutveckling.  
 
Sant   Falskt   Vet inte  
 
9. Jag anser att antibiotikakurerna vid okomplicerad (nedre) UVI på särskilda boenden ofta är  
   
a. För korta    
b. För långa    
c. Lagom långa    
d. Inget av ovanstående  
 
10. Jag anser att man ofta  
a. Överbehandlar UVI hos äldre på särskilda boenden   
b. Underbehandlar UVI hos äldre på särskilda boenden   
e. Inget av ovanstående        
 
11.  
a. När äldre män har UVI ska man vid behandlingsvalet alltid ta hänsyn till att prostata kan 
vara inblandad 
Sant   Falskt   Vet inte  
 
b. Vid UVI ska man behandla äldre män med längre antibiotikakurer än äldre kvinnor 
Sant   Falskt   Vet inte  
 
D. Fallbeskrivningar 
 
12. Astrid, 82 år bor på boendet Storken. Hon har besvär som tyder på okomplicerad (nedre) UVI, 
vilket bekräftas av läkare. Astrid är allergisk mot penicillinpreparat. 
 
a. Bactrim (trimetoprim-sulfa) är förstahandspreparat i detta fall  
Sant   Falskt   Vet inte  
 
b. Furadantin (nitrofurantoin) är ett av de rekommenderade medlen 
Sant   Falskt   Vet inte  
 
c. Cefamox (cefadroxil) är ett av de rekommenderade medlen 
Sant   Falskt   Vet inte 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13. Elin, 76 år som också bor på Storken har haft smärtsamma och frekventa miktioner de senaste 
två dagarna. Nitrittestet som tas av sjuksköterskan på boendet är positivt.  
 
a. Eftersom nitrittestet är positivt behöver inte sedimentet kontrolleras 
Sant   Falskt   Vet inte  
 
b. Eftersom nitrittestet är positivt behöver ingen urinodling göras 
Sant   Falskt   Vet inte  
 
c. Eftersom nitrittestet är positivt behöver ingen dipslide göras 
Sant   Falskt   Vet inte  
 
 
Allmänläkaren drar slutsatsen att Elin har en okomplicerad (nedre) UVI och bestämmer sig för 
att behandla henne med Trimetoprim. Allmänläkaren vill få in ytterligare ett urinprov efter 
avslutad behandling som en behandlingskontroll.  
 
d. Att kontrollera urinen efter behandlingen är korrekt i detta fall 
Sant   Falskt   Vet inte  
 
14. Elin, 76 år (se fråga 13) får åter besvär med urinvägarna två månader senare. Läkaren sätter åter 
in antibiotika efter konstaterad okomplicerad (nedre) UVI.  
 
a. Trimetoprim kan rekommenderas i detta fall 
Sant   Falskt   Vet inte  
 
b. Selexid (pivmecillinam) kan rekommenderas i detta fall 
Sant   Falskt   Vet inte  
 
c. Kinoloner exempelvis Lexinor (norfloxacin) är att rekommendera eftersom patienten fick 
trimetoprim förra gången 
Sant   Falskt   Vet inte  
 
d. Trimetoprim + sulfa exempelvis Bactrim vore att föredra eftersom patienten endast fick 
trimetoprim förra gången 
Sant   Falskt   Vet inte  
 
15. Elin (se 13-14) har ständiga problem med urinvägarna. Sjuksköterskan undrar vad hon ska göra. 
Läkaren föreslår att de ska prova lågpotent östrogen (östriol) i tablettform eftersom Elin har 
sköra slemhinnor. 
 
a. Östriol kan ha en positiv effekt i detta fall 
Sant   Falskt   Vet inte  
 
b. Hiprex (metenaminhippurat) hade kunnat vara ett alternativ till östrogen 
Sant   Falskt   Vet inte  
 
16. Berta 79, som bor på ett särskilt boende har fått diagnosen okomplicerad (nedre) UVI. 
Allmänläkaren behandlar henne med Selexid (pivmecillinam) 200 mg 3 gånger dagligen i 5 
dagar. 
 
a. Behandlingstidens längd är korrekt 
Sant   Falskt   Vet inte  
 
b. Trimetoprim är billigare (=sant). Därför hade det varit ett bättre alternativ i detta fall. 
Sant   Falskt   Vet inte 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Forts. 16 
Berta får återigen besvär efter en månad och läkaren konstaterar okomplicerad (nedre) UVI. 
Denna gång förskriver allmänläkaren Selexid (pivmecillinam) 200 mg 3 gånger dagligen i 10 
dagar. 
 
c. Det var korrekt att öka behandlingstidens längd 
Sant   Falskt   Vet inte  
 
 
17. Konrad 91, som bor i egen lägenhet på servicehuset Delsbo, har konstaterad UVI. Läkaren 
förskriver därför Trimetoprim 160 mg 2 gånger dagligen i 14 dagar. 
 
a. Trimetoprim är ett korrekt val 
Sant   Falskt   Vet inte  
  
b.  Trimetoprim + sulfa  t.ex Bactrim är att föredra 
Sant   Falskt   Vet inte  
 
c. Ett kinolonpreparat (t.ex. Lexinor) vore det bästa för Konrad 
Sant   Falskt   Vet inte  
 
d. Behandlingstiden, 14 dagar, är för lång 
Sant   Falskt   Vet inte  
 
 
18. Ernst 79, har UVI med misstanke om prostataengagemang. 
 
c. Trimetoprim 160 mg 2 gånger dagligen i 14 dagar är ett bra alternativ 
Sant   Falskt   Vet inte  
 
d. Lexinor (norfloxacin) är ett bättre alternativ än trimetoprim i detta fall 
Sant   Falskt   Vet inte  
 
19. Ester 82, har inte mått bra de senaste två dagarna. Nitrittestet är positivt. Hon har ingen feber 
och har KAD (kvarkateter). Sjuksköterskan ringer och undrar om hon kan börja ge en 
antibiotikakur. Allmänläkaren tycker att det låter bra och föreslår att hon tar Selexid 
(pivmecillinam) som finns i läkemedelskåpet eftersom Ester fick Trimetoprim för två månader 
sedan. 
 
a. Det är korrekt att ordinera antibiotika i detta fall 
Sant   Falskt   Vet inte  
 
b. Byte av preparat rekommenderas trots att Trimetoprim fungerade bra förra gången 
Sant   Falskt   Vet inte 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E. Nedan finner Du ett antal påståenden angående urinvägsinfektioner hos äldre på 
särskilda boenden. Ange om Du instämmer eller ej i dessa påståenden genom att 
markera den ruta som bäst överensstämmer med din åsikt. 
 
 
 
20. En okomplicerad nedre UVI hos en kvinna över 65 år ska behandlas med antibiotika under minst       
7 dagar 
      
 
Instämmer inte alls              Instämmer helt  
     1   2   3   4 
 
21. När en kvinna som bor på ett särskilt boende får upprepade okomplicerade UVI inom några månader 
ska ett annat antibiotika väljas än det som skrevs ut vid första episoden. 
 
 
Instämmer inte alls              Instämmer helt  
     1   2   3   4 
 
22. Till postmenopausala kvinnor med återkommande UVI kan ett peroralt lågdosöstrogenpreparat vara 
av värde. 
 
 
Instämmer inte alls              Instämmer helt  
     1   2   3   4 
 
23. Till postmenopausala kvinnor med återkommande UVI kan ett lokalt östrogenpreparat vara av 
värde. 
 
 
Instämmer inte alls              Instämmer helt  
     1   2   3   4 
 
24. Sjuksköterskan bestämmer i praktiken om urinvägsinfektioner ska behandlas eller inte 
 
 
Instämmer inte alls              Instämmer helt  
     1   2   3   4 
 
25. Sjuksköterskan bestämmer i praktiken vilket preparat som förskrivs vid urinvägsinfektioner 
 
 
Instämmer inte alls              Instämmer helt  
     1   2   3   4 
 
 
 
 
Ifylld enkät sätts in i SANT-pärmen 
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Kunskaps/Attitydenkät för Urinvägsinfektioner vid särskilda 
boenden. Ifylld enkät sätts in i SANT-pärmen. 
Datum:   
Utbildning 
Sjuksköterska   Leg år 
Vidareutbildning   Ja, i så fall ange inom vilket område  
Distriktsköterska    
 
Anställningsform / anknytning till boendet 
Tillsvidareanställning     
Pooltjänst       
Vikariat        
Tillfälligt inkallad      
Annat        
 
Hur länge har Du haft kontakt med detta särskilda boende? 
          år 
 
Nedan finner du flera påståenden kring UVI. Ange för varje påstående om Du anser att 
det är sant eller falskt eller om Du inte vet om det är sant eller falskt.  
 
A. Symtombilden hos äldre 
 
1. Förvirring kan vara det enda symtomet hos äldre med UVI 
 
Sant   Falskt  Vet inte  
 
2. Vid UVI som kräver antibiotikabehandling är feber alltid ett symtom 
 
Sant   Falskt  Vet inte  
 
B. Diagnostik 
 
3. Om den boende har feber och symtom som tyder på UVI ska man göra en odling. 
Sant   Falskt  Vet inte  
  
4. Vid fynd av bakterier i urinen ska man alltid behandla. 
Sant   Falskt  Vet inte  
 
5. Falskt negativt nitrittest kan bero på följande: 
 
a. Kort blåsinkubationstid     Sant   Falskt  Vet inte 
b. Lågt bakterieantal i urinen   Sant   Falskt  Vet inte 
c. Intag av höga doser C-vitamin  Sant   Falskt  Vet inte 
d. Intag av järntabletter    Sant   Falskt  Vet inte 
e. Bakteriearten går ej att påvisa   Sant   Falskt  Vet inte 
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6. Falskt positivt nitrittest kan bero på följande: 
 
a. Vissa läkemedel     Sant   Falskt  Vet inte 
b. Fördröjd avläsningstid    Sant   Falskt  Vet inte 
 
7.  
i) Urin till nitrittestet tar jag från: (Rangordna även följande alternativ där 1 är det som är bäst) 
            ii) Rangordning 
a. Blöja     Ja    Nej  Vet inte    __ 
b. Kvällsurin    Ja    Nej  Vet inte    __ 
c. Morgonurin    Ja    Nej  Vet inte    __ 
 
iii) Hur länge bör urinen minst ha stått i blåsan för att nitrittestet ska vara tillförlitligt? 
 15 min   1 h   4 h   6 h 
 
8. Urin från KAD, kvarkateter, ger tillförlitliga resultat på nitritstickan 
 
Sant   Falskt   Vet inte  
 
9. Vem läser av stickor på ert boende?       
 
Sjuksköterskor   Undersköterskor    Vårdbiträden    Det varierar  
 
 
 
C. Behandling, generellt 
 
10. Om en patient får tillbaka en okomplicerad (nedre) UVI inom två månader efter första episoden, 
bör läkaren välja ett annat preparat än han/hon gjorde första gången pga risken för 
resistensutveckling.  
 
Sant   Falskt   Vet inte  
 
11. Jag anser att antibiotikakurerna vid okomplicerad UVI på särskilda boenden ofta är  
   
a. För korta    
b. För långa    
c. Lagom långa    
d. Inget av ovanstående  
 
12. Jag anser att man ofta  
a. Överbehandlar UVI hos äldre på särskilda boenden   
b. Underbehandlar UVI hos äldre på särskilda boenden   
e. Inget av ovanstående        
 
D. Fallbeskrivningar 
 
 
13. Elin, 76 år, bor på Storken har haft smärtsamma och frekventa miktioner de senaste två dagarna. 
Nitrittestet som tas av sjuksköterskan på boendet är positivt.  
 
a. Eftersom nitrittestet är positivt behöver inte sedimentet kontrolleras 
Sant   Falskt   Vet inte  
 
b. Eftersom nitrittestet är positivt behöver ingen urinodling göras 
Sant   Falskt   Vet inte  
 
c. Eftersom nitrittestet är positivt behöver ingen dipslide göras 
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Sant   Falskt   Vet inte  
 
Forts. 13 Allmänläkaren drar slutsatsen att Elin har en okomplicerad (nedre) UVI och bestämmer sig för 
att behandla henne med Trimetoprim. Allmänläkaren vill få in ytterligare ett urinprov efter 
avslutad behandling som en behandlingskontroll.  
 
d. Att kontrollera urinen efter behandlingen är korrekt i detta fall 
Sant   Falskt   Vet inte  
 
14. Elin (se 13) har ständiga problem med urinvägarna. Sjuksköterskan undrar vad hon ska göra. 
Läkaren föreslår att de ska prova lågpotent östrogen (östriol) i tablettform eftersom Elin har 
sköra slemhinnor. 
 
a. Östriol kan ha en positiv effekt i detta fall 
Sant   Falskt   Vet inte  
 
b. Hiprex (metenaminhippurat) hade kunnat vara ett alternativ till östrogen 
Sant   Falskt   Vet inte  
 
15. Berta 79, som bor på ett särskilt boende har fått diagnosen okomplicerad (nedre) UVI. 
Allmänläkaren behandlar henne med Selexid (pivmecillinam) 200 mg 3 gånger dagligen i 5 
dagar. 
 
a. Behandlingstidens längd är korrekt 
Sant   Falskt   Vet inte  
 
Berta får återigen besvär efter en månad och läkaren konstaterar okomplicerad UVI. Denna 
gång förskriver allmänläkaren Selexid (pivmecillinam) 200 mg 3 gånger dagligen i 10 dagar. 
 
b. Det var korrekt att öka behandlingstidens längd 
Sant   Falskt   Vet inte  
 
 
16. Ernst 79, har konstaterad UVI. 
 
a. När äldre män har UVI ska man vid behandlingsvalet alltid ta hänsyn till att prostata kan 
vara inblandad 
Sant   Falskt   Vet inte  
 
b. Vid UVI ska man behandla äldre män med längre antibiotikakurer än äldre kvinnor 
Sant   Falskt   Vet inte  
 
17. Ester 82, har inte mått bra de senaste två dagarna. Nitrittestet är positivt. Hon har ingen feber 
och har KAD (kvarkateter). Sjuksköterskan ringer och undrar om hon kan börja ge en 
antibiotikakur. Allmänläkaren tycker att det låter bra och föreslår att hon tar Selexid 
(pivmecillinam) som finns i läkemedelskåpet eftersom Ester fick Trimetoprim för två månader 
sedan. 
 
a. Det är korrekt att ordinera antibiotika i detta fall 
Sant   Falskt   Vet inte  
 
b. Byte av preparat rekommenderas trots att Trimetoprim fungerade bra förra gången 
Sant   Falskt   Vet inte 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E. Nedan finner Du ett antal påståenden angående urinvägsinfektioner hos äldre på 
särskilda boenden. Ange om Du instämmer eller ej i dessa påståenden genom att 
markera den ruta som bäst överensstämmer med din åsikt. 
 
 
 
18. En okomplicerad nedre UVI hos en kvinna över 65 år ska behandlas med antibiotika under minst      
7 dagar 
 
Instämmer inte alls              Instämmer helt  
     1   2   3   4 
 
19. När en kvinna som bor på ett särskilt boende får upprepade okomplicerade UVI inom några månader 
ska ett annat antibiotika väljas än det som skrevs ut vid första episoden. 
 
 
Instämmer inte alls              Instämmer helt  
     1   2   3   4 
 
20. Till postmenopausala kvinnor med återkommande UVI kan ett peroralt lågdosöstrogenpreparat vara 
av värde. 
 
 
Instämmer inte alls              Instämmer helt  
     1   2   3   4 
 
21. Till postmenopausala kvinnor med återkommande UVI kan ett lokalt östrogenpreparat vara av 
värde. 
 
 
Instämmer inte alls              Instämmer helt  
     1   2   3   4 
 
22. Sjuksköterskan bestämmer i praktiken om urinvägsinfektioner ska behandlas eller inte 
 
 
Instämmer inte alls              Instämmer helt  
     1   2   3   4 
 
23. Sjuksköterskan bestämmer i praktiken vilket preparat som förskrivs vid urinvägsinfektioner 
 
 
Instämmer inte alls              Instämmer helt  
     1   2   3   4 
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Appendix VI
SANT-trial, Swedish Antibiotic Nursing home Trial 
A collaboration between Strama, Karolinska Institutet and Apoteket AB 
 
 
Appendix VII 
 
We would like to have your views on the content and form of this continuing medical education. 
Mark to what extent you agree to the statements below. Put a circle around the figure you think 
have the best correlation to your own view. 
       
       
 
  
1. a. The education was well worth the time  1  2  3  4  5  6 
 
 b. I received good guidance for my everyday work  1  2  3  4  5  6 
 
 c. The content of this meeting was worthwile for me  1  2  3  4  5  6 
 
 d. The meeting was stimulating   1  2  3  4  5  6 
 
 e. The meeting was well-structured   1  2  3  4  5  6 
 
 f. I perceived as if  I was dictated how to do my work  1  2  3  4  5  6 
 
 g. To much time was spent on questions not related to the subject 1  2  3  4  5  6 
 
 h. I think that the group regarded my knowledge and skills 1  2  3  4  5  6 
 
 i. I think I regarded the knowledge and skills of the group 1  2  3  4  5  6 
 
 
2.  a. The physician had adequate knowledge  1  2  3  4  5  6 
 
 b. The physician stimulated the discussion  1  2  3  4  5  6 
 
 c. The pharmacist had adequate knowledge  1  2  3  4  5  6 
 
 d. The pharmacist stimulated the discussion  1  2  3  4  5  6 
 
 e. The hygiene nurse had adequate knowledge  1  2  3  4  5  6 
 
 f. The hygiene nurse stimulated the discussion  1  2  3  4  5  6 
 
 
Profession (Nurse/physician):................................       County: .............................Date:............. 
 
If you have any other views or suggestions you would like to share, please write on the reverse 
page. Thank You for your contribution! 
Strongly 
disagree 
Strongly 
agree 
Appendix VIII 
 
Appendix VIII. Results from the participants’ written evaluation of the educational intervention.
      
 
All participants, n=105
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Antibiotic Prescribing in Outpatients: a 1-Week
Diagnosis–Prescribing Study in 5 Counties in
Sweden
CECILIA STA LSBY LUNDBORG1, EVA OLSSON1, SIGVARD MO LSTAD2, and the
Swedish Study Group on Antibiotic Use*
From the 1Department of Public Health Sciences, Diision of International Health (IHCAR), Karolinska Institutet and
Apoteket AB, Stockholm, Sweden, 2Unit of Research and Deelopment in Primary Care, Jo¨nko¨ping, Sweden, 3Center for
Clinical Research, Dalarna and Primary Care, Diision of Medicine and Care, Faculty of Health Sciences, Linko¨ping,
Sweden, 4Department of Paediatrics, O stersund County Hospital and Department of Health Sciences, Mid Sweden
Uniersity, O stersund, Sweden, 5Department of Paediatrics, Karolinska Hospital, Stockholm, Sweden, 6Department of
Clinical Pharmacology, Institute for Medicine and Care, Faculty of Health Sciences, Linko¨ping, Sweden, 7Department of
Infectious Diseases, Uniersity Hospital, MAS, Malmo¨, Sweden, 8Department of Infectious Disease Control, Central
Hospital of Va¨xjo¨, Va¨xjo¨, Sweden, 9Department of Public Health and Caring Sciences/Family Medicine, Uppsala
Uniersity, Uppsala, Sweden, 10Department of Public Health Sciences, IHCAR, Karolinska Institutet, Stockholm, Sweden
and 11National Board of Health and Welfare, Stockholm, Sweden
A diagnosis–antibiotic prescribing study initiated by the Swedish Strategic Programme for the Rational Use of Antimicrobial
Agents and Surveillance of Resistance was performed in 5 counties in Sweden (total 1,290,000 inhabitants) during 1 week in
November 2000. The aims of the study were to analyse diagnoses and antibiotics prescribed for outpatients and to appraise
the feasibility of the data collection method. Physicians in primary care and departments of ENT, paediatrics and infectious
diseases completed a questionnaire for each patient with an infectious disease complaint, including information about age, sex,
diagnosis, diagnostic methods used and treatment. When an antibiotic was prescribed, the type and duration of treatment were
noted. A total of 7,071 forms were returned, of which 7,029 included information on diagnosis; infections of the respiratory
tract, urinary tract and the skin or soft tissues were responsible for 70%, 14% and 10% of the visits, respectively. Antibiotics
were prescribed in 59% of all cases and phenoxymethylpenicillin was the most commonly prescribed antibiotic. Of the forms
returned, 94% emanated from primary care centres. In conclusion, this study provides information on the treatment pattern
associated with various diagnoses and the pattern of use of various antibiotics. Such a study is relatively simple to perform
and entails only a small extra workload for the participants.
C. Sta˚lsby Lundborg, IHCAR, Department of Public Health Sciences, Karolinska Institutet, SE-171 76 Stockholm, Sweden.
E-mail : cecilia.stalsby.lundborg@phs.ki.se
INTRODUCTION
Antibiotic resistance is increasing worldwide and intensiﬁed
measures are called for globally as well as in individual
countries in order to curb this trend (1–3). There is a concern
that the irrational use of antibiotics can contribute to this
increase in resistance (1).
The Swedish Strategic Programme for the Rational Use of
Antimicrobial Agents and Surveillance of Resistance
(STRAMA) was initiated in 1994 as a national network in
Sweden (4, 5) in order to give these issues national promi-
nence. An increasing trend in the sale of antibiotics for
systemic use was seen in Sweden at the end of the 1980s, from
14.1 deﬁned daily doses (DDD)/1,000 inhabitants and days
(TID) in 1986 to a peak in 1993 of 19.4 DDD/TID.
Subsequently a decrease has occurred to a total of 15.8
DDD/TID in 1999 (6), of which 14.4 DDD/TID were
dispensed for outpatients, a low ﬁgure from a European
perspective, whereas a range between 8.9 and 36.5 DDD/TID
was seen in 1997 (7).
In order to obtain detailed information concerning how
various diseases are treated and for which diseases speciﬁc
drugs are used, the Swedish Diagnosis Prescription Study
(DPS) was initiated in 1978. Owing to a decreasing partici-
pation rate, in particular for general practitioners (GPs), its
validity has been questioned and the study, in its present
form, will be ended in 2002. It is important to create a valid
and comparable picture of the proportion of patients with
infectious symptoms who are prescribed antibiotics, for
which diagnoses antibiotics are prescribed and the relations
between different types of antibiotics for each diagnosis.
Such information is essential in the development of both
clinical practice guidelines and contextualized educational
materials. The National Board of Health and Welfare in
Sweden has proposed the development of a system (known
as SPAR) for continuous follow-up of antibiotic prescribing
and the reasons for prescribing, in hospitals as well as in
outpatient care (8). However, the present study was con-
ducted awaiting the implementation of this system. Recent
statistics shows that 90% of antibiotics are prescribed for
* Malin Andre3, Inge Axelsson4, Margareta Eriksson5, Mikael
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Rolf Wahlstro m10,11
© 2002 Taylor & Francis. ISSN 0036-5548 DOI: 10.1080/00365540110080647
Scand J Infect Dis 34 Antibiotic prescribing by diagnosis in outpatients 443
outpatients whereas 50% of both DDDs and prescrip-
tions emanate from the primary care sector (6).
The main aim of this study was to present diagnosis and
antibiotic-prescribing information for outpatients with in-
fectious disease complaints in 5 counties in Sweden who
sought treatment during a 1-week period. A further aim
was to appraise the feasibility of this kind of survey and to
see whether it could be recommended for possible use in the
future.
MATERIALS AND METHODS
A prospective study was conducted simultaneously in 5 counties in
Sweden during 1 week in November 2000. There are usually a high
number of patients with infectious symptoms in November but
winter epidemics of inﬂuenza and respiratory syncytial virus usu-
ally occur after this time. The participating counties were selected
so as both to achieve a geographical spread and incorporate low-,
medium and high-prescribing counties. The participating counties
were Uppsala (16.5 DDD/TID), O stergo¨tland (13.8 DDD/TID),
Kronoberg (16.4 DDD/TID), Dalarna (12.9 DDD/TID) and Ja¨mt-
land (12.7 DDD/TID), the ﬁgures in parentheses showing the sales
of antibacterials for systemic use in 1999 (ATC code J01, version
1999; not including nitrofurantoin and fosfomycin) (6).
In each county, 1 or 2 persons were responsible for informing
and communicating with participating doctors. These individuals
were typically involved in local STRAMA groups working towards
the rational use of antibiotics and were well known among their
colleagues. In order to ensure anonymity, the participating doctors
were usually recruited as part of teams in primary care centres or
hospital departments. Both public and private surgeries, where
available, were included. In total, 155 primary care centres (600
doctors), 24 hospital departments or specialized surgeries (ENT,
infectious diseases and paediatrics) and 20 individual private prac-
titioners agreed to participate. A number of measures were taken
to ensure a high participation rate:
1. Written information regarding the study was in most cases
provided twice to all potential participants;
2. Oral information was provided to key persons in each county;
and
3. In some cases, information meetings were conducted for larger
groups of doctors.
The study began at 08.00 on Monday 20 November, 2000 and
ended at 08.00 on Monday 27 November, 2000. The physicians
were asked to complete a form for all patients with a respiratory
tract infection (RTI), a urinary tract infection (UTI), a skin/soft
tissue infection or another type of infection. The forms were to be
completed irrespective of whether the patient was prescribed an
antibiotic or not. Only 1 diagnosis per form was to be given and
only antibiotics for oral systemic use were included (ATC code J01,
version 2001; includes nitrofurantoin and fosfomycin). Disorders
normally treated with topical antibiotics, such as conjunctivitis,
were excluded. The questionnaire form was a slightly modiﬁed
version of 1 used previously in Finland (9, 10). The number of
items was reduced in order to minimize the effort required from
the participating doctors. The included items were discussed by
members of the Swedish Study Group on Antibiotic Use following
consultations with other practitioners. The ﬁnal version of the
form was piloted in a small group of GPs and found to be
acceptable. The main topics of the questionnaire form are listed in
Table I. For each item, the doctor was asked to choose between
pre-formulated response alternatives but could use a written alter-
native when these were not considered suitable. The choice of
Table I. Main topics included in the questionnaire
Sex and year of birth1.
2. Visit: new, i.e. ‘‘ﬁrst’’, visit or return visit. If return visit,
was the patient already receiving antibiotic treatment?
Time of visit: working hours or emergency hours3.
Duration of symptoms (d)4.
5. Main diagnosis
Diagnostic techniques used6.
7. Treatment with antibiotics (yes/no), referral or both
Type of antibiotic and treatment duration8.
Factors inﬂuencing the choice of treatment9.
antibiotic (generic or trade name) and the duration of treatment
had to be written by hand. Dosage was not included. Detailed
information for the doctor was printed on the reverse of each
form. A full version of the questionnaire (in Swedish) is available
from the corresponding author.
Each participating doctor collected the completed forms anony-
mously in envelopes. For each envelope, the county, physician
category and type of surgery were recorded. The envelopes were
sent to the Department of Public Health Sciences, Karolinska
Institutet, Stockholm, where the data were entered into a computer
and descriptively analysed using SPSS version 10.0. For this overall
analysis it was decided not to separate the results into primary care
and other outpatient care facilities, but to treat the data as a
whole.
To validate the data, additional data were collected from
Apoteket AB (National Corporation of Swedish Pharmacies).
These data included data from each participating county concern-
ing dispensed antibiotics for the week of the study, the week before
and the week after. Furthermore, data were collected regarding the
proportion of antibiotics prescribed by different physician cate-
gories in November 2000 from 2 counties (Dalarna and Uppsala).
We calculated the number of completed forms per 1,000 inhabi-
tants per county and the number of forms with prescribed antibi-
otic per dispensed antibiotic in each county during the study week.
For all counties the percentage of forms emanating from primary
care centres was calculated. In addition, for Uppsala and Dalarna,
the proportion of dispensed antibiotic prescriptions emanating
from primary care centres as a percentage of all the included types
of department was analysed for the entire month of November
2000. These comparative data were analysed for face validity.
RESULTS
A total of 7,071 forms were returned and the forms were
generally completed according to instructions. In a few
cases (20), 1 of the included diagnoses had been
marked despite a clear instruction that only 1 diagnosis
should be given. In those cases, by examining the diagnosis
and the prescribed drug, the most relevant diagnosis was
recorded. In some cases the form had also been completed
for non-infectious symptoms or for drugs not belonging to
ATC code J01. These forms were excluded from the
analysis.
In the analysis, 7,029 patient cases were included. The
remaining forms lacked diagnosis information. Of these
7,029 forms, 6,738 included information on the type of
surgery, which in 92% of cases was primary care centres.
There were 133 forms from ENT, 334 from paediatric and
100 from infectious disease departments. In 6,900 forms
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both the sex (58% female, 42% male) and age of the patient
was given. The age group for which the highest number of
forms had been completed was children aged 0–7 y (25%;
n=1718) (Fig. 1).
In 84% of cases the visit was a ﬁrst visit and 68% of the
visits were made on weekdays between 08.00 and 17.00. The
duration of symptoms before consultation was 1–7 d in 56%
of cases but 17% of patients had had their symptoms for
14 d.
A total of 70% of visits were for a RTI, 14% for a UTI,
10% for a skin/soft tissue infection and 6% for other
infections. Overall, an antibiotic was prescribed in 59% of
cases. The group of diagnoses with the highest rate of
antibiotic prescriptions was UTIs (87%), followed by skin/
soft tissue infections (74%) and RTIs (54%) (Table II).
Detailed information on cases already receiving treatment
and on referral/hospitalization is also presented per
diagnosis.
On the form throat infections were divided into streptococ-
cal tonsillitis and pharyngitis. In 779 cases the throat
infection was classiﬁed as streptococcal tonsillitis. Of these,
98% were treated with an antibiotic. For the diagnosis
pharyngitis, 10% were treated with antibiotics. Of the pneu-
monia cases 30% were classiﬁed as atypical.
In 60% (n=4,248) of cases with a given diagnosis some
kind of diagnostic technique, as speciﬁed in the form, was
used. The most common was the CRP test, which was used
in 36% of RTIs, 15% of UTIs, 11% of skin/soft tissue
infections and 42% of other infections. A diagnostic tech-
nique was used in 62% (n=2,586) of the cases where an
antibiotic was prescribed. The CRP test was also the most
commonly used in this setting, being used in 44% of cases.
For RTIs, a rapid streptococcal test was used in 27% of cases
where an antibiotic was prescribed.
For RTIs, phenoxymethyl penicillin (PcV) was the most
commonly prescribed antibiotic, being prescribed in 62% of
cases, and tetracylines were the next commonest, being
prescribed in 14% of cases (Table III). In UTIs, trimetho-
prim, extended-spectrum penicillins (almost exclusively
pivmecillinam) and quinolones were prescribed in 30% of
cases each. Cotrimoxazole, fosfomycin and nitrofurantoin all
had limited use. Of the skin/soft tissue infections treated with
antibiotics, isoxazolyl penicillins (mainly ﬂucloxacillin) were
used in 51% of cases, PcV in 23% and cephalosporins in 12%.
The duration of treatment was provided in 4,082 cases. The
overall duration of treatment varied from 1 to 360 d. For
tonsillitis it was 10 d in 96% of cases. For uncomplicated
UTI, a 7-day treatment duration was recommended in 77%
of cases.
The choice of treatment was reported to be inﬂuenced by
various speciﬁed factors (1 or more choices were possible) in
1,112 cases, the most common being that the patient was
difﬁcult to judge (n=340). Therapeutic failure was men-
tioned in 194 cases, previous skin reactions or vomiting for
penicillin in 97 cases, previous urticaria, etc. for penicillin in
83 cases, other diseases, such as diabetes, chronic obstructive
pulmonary disease or other chronic diseases, in 292 cases and
special requests by the patient in 188 cases.
The number of completed forms per 1,000 inhabitants
ranged from 3.73 to 7.68 for the 5 counties, with a mean of
5.48. During the study week, a total of 9,820 prescriptions
for oral antibiotics were dispensed in the 5 counties, with
approximately the same numbers for the weeks before and
after the study. The approximate proportion of antibiotics
dispensed in the counties as revealed from the forms was 41%
(range 33–48%). The physician specialities included in our
study were responsible for 70% of dispensed antibiotic
prescriptions in Dalarna and O stergo¨tland, where the pre-
scriber category was examined for all prescriptions. When
examining the primary care share of forms and dispensed
prescriptions in those counties, the ﬁgures were almost
identical at 93.3% and 93.5% for Dalarna and 91.1% and
91.0% for O stergo¨tland, respectively.
DISCUSSION
This is the ﬁrst large-scale study in Sweden to have collected
information on physicians’ treatments and choices of antibi-
otics for outpatients consulting for infectious symp-
Fig. 1. The age and sex distributions of the included patients.
Scand J Infect Dis 34 Antibiotic prescribing by diagnosis in outpatients 445
toms. The data make it possible to study the treatment
patterns for various diagnoses as well as the patterns of use
for various antibiotics.
The results conﬁrm that RTIs are the most common
infections encountered in outpatient care. They also show
that Swedish physicians prescribe PcV to a high degree
compared to physicians in other countries. In this study,
PcV constituted 44% of all prescribed antibiotics, compared
to a study in Norway in which the proportion was 32% (11)
and studies in Finland in which the proportions were 17%
(9) and 13% (10). The proportion of RTIs was almost the
same in our study as in the Finnish studies, which were
conducted in a similar way to ours. In the Norwegian
study, the proportion of RTIs was somewhat lower.
For most diagnoses, the antibiotic prescribing pattern
seemed to be in relatively good accordance with Swedish
recommendations. PcV was prescribed in most cases of
acute otitis media and acute pharyngotonsillitis, especially
if cases of therapeutic failure or relapse were excluded.
However, it was noted that 90% of children with acute
otitis media were prescribed an antibiotic, despite the re-
cently issued, and more restrictive, treatment recommenda-
tions for otitis media in children aged 2 y (12). Cases
with the diagnosis pharyngitis were treated with antibiotics
in only 10% of cases, compared to 21% in a Finnish study
(9), which may reﬂect differences in treatment or diagnostic
traditions. However, it is also possible that the high use of
rapid streptococcal tests in this study inﬂuenced the pattern
of diagnosis and that the diagnosis pharyngitis was used in
this study when diagnostic tests were negative and the
diagnosis tonsillitis when they were positive. According to
Swedish tradition, isoxazolylpenicillins are often used for
skin and soft tissue infections. This was also evident in this
study, where 50% of skin and soft tissue infections was
treated with isoxazolylpenicillins whereas cephalosporins
were only used in 12% of cases, as opposed to the situation
in Finland where cephalosporins were used in 82% of cases
(10). According to Swedish recommendations macrolides
are not recommended as ﬁrst-choice drugs in most situa-
tions and the dominance of erythromycin is probably due
to therapeutic tradition, as other macrolides are also
available.
Some potential deviations from guidelines could be dis-
cerned. It is, however, difﬁcult to judge the appropriateness
Table II. Diagnosis and cases with information regarding treatment
Cases with information on treatment (n=6,977a)
Referral/On treatment, Treatment with
hospitalization antibiotics (n=4,170);Total no. of cases no change
(n=7,029); n (%) (n=115); nDiagnosis (n=131); n % treated per diagnosis
707101,193 (17)Throat infection
5 71,276 (18) 11URTI
21 89Pneumonia 403 (6) 9
1020 (0.3)Inﬂuenza
33610515 (7)Unspeciﬁed lower RTI
814 91657 (9)Otitis media
Sinusitis 94393 (6) 10 1
Bronchitis, acute 411 (6) 9 2 50
Bronchitis, exacerbation of chronic bronchitis 75 (1) 1 87
5454RTI, all 734,943 (70)
Lower UTI 683 (10) 3 93
Recurrent UTI 136 (2) 3 89
9 78Upper UTI 59 (0.8) 3
Urethritis 74 (1.1) 1 40
UTI, all 952 (14) 10 9 87
Erysipelas 83 (1.2) 2 7 82
Leg ulceration 52 (0.7) 6 2 67
79369 (5) 78Boil, abcess, ulcer, impetigo
175 (2.5)Other 5 5 65
Skin/soft tissue infections, all 679 (10) 22 21 74
455 (6) 32Other 5010
131115 597,029 (100)All infections
a In total, 2,561 cases were given no treatment. The discrepancies in numbers are due to missing values.
URTI=upper respiratory tract infection; RTI=respiratory tract infection; UTI=urinary tract infection.
C. Sta˚lsby Lundborg et al. Scand J Infect Dis 34446
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of prescribing in individual cases without a detailed exami-
nation of patient records or at the very least an analysis of
the diagnostics measures taken.
A total of 33% of cases classiﬁed as unspeciﬁed lower
RTI, which includes cough, were treated with an antibiotic,
as well as 50% of cases of acute bronchitis. In addition,
there was a relatively high proportion of tetracyclines pre-
scribed for those infections, as well as for pneumonia and
exacerbation of chronic bronchitis (Table III). It is, how-
ever, difﬁcult to devise guidelines for unspeciﬁc diagnoses.
The proportion of cases of acute bronchitis that were
treated with an antibiotic was however lower compared to
1 of the Finnish studies (10), in which 71% of cases were
treated.
The surprisingly high number of diagnostic tests made
for RTIs, especially of CRP, requires further analysis.
Another example of a potential deviation from guidelines
was that quinolones were used in 21% of females with a
lower UTI, a non-recommended treatment (13). This level
of non-recommended use was lower than ﬁgures reported in
the DPS for 2000 (6) and in an earlier study (14). This may
reﬂect a shift towards recommended drugs or may be
because the DPS does not distinguish between complicated
and uncomplicated UTIs. It may also be a sign of socially
desirable responses.
To estimate the face validity of the data we made a
number of comparisons, from which we drew the conclu-
sion that the data could be regarded as a relatively good
estimate of antibiotic prescribing in these counties during
the study week. The inter-county variation in the number
of forms returned per 1,000 inhabitants was 2-fold. This
may depend on differences in physician availability but
calls for a somewhat cautious interpretation of the data.
When the number of forms with an antibiotic prescribed
was divided by the total number of antibiotic prescriptions
dispensed during the study week, the ﬁgures varied to a
smaller degree. Finally, for the 2 counties where we com-
pared the proportion of forms emanating from primary
care centres during the study week to the proportion of
dispensed prescriptions for the entire month of November
in the same 2 counties emanating from primary care cen-
tres, the ﬁgures were amazingly similar. This is likely to
indicate a more or less random inclusion of cases, and that
the forms seem to correspond relatively well to reality for
the included prescriber categories.
The actual response rate for the included prescriber
categories is difﬁcult to establish. Unpublished statistics
from the county of O stergo¨tland have previously shown
that 43% of all antibiotic prescribing emanates from pri-
mary care centres. This corresponds well to our data.
Theoretically, there are 2 main categories of low response
rate:
1. Elected responses, where only physicians already com-
plying with recommendations participate, or each par-
ticipating physician ﬁlls in the forms only for some of
his/her patients, those for whom the physician feels that
the treatment was really justiﬁed, or shifting of diagno-
sis to a more ‘‘justiﬁed’’ diagnosis (15); and
2. Random responses, where the physician either partici-
pates or not and when s/he participates s/he ﬁlls in the
form for most of the patients, without further analysis.
The consequences of these different response problems
are somewhat different. In this study, the participating
physicians remained anonymous, which should reduce the
problems of elected responses, but such an inﬂuence could
not be completely disregarded. Random responses are less
problematic as long as the response rate is relatively high.
As the included prescriber categories only represent 
70–75% of all prescriptions during the month when the
study was done, it would be useful to include all prescriber
categories for humans in future studies. It might be the case
that the prescriber categories included here, due to exten-
sive experience of antibiotic prescribing, have patterns that
coincide relatively well with recommendations and that
other prescriber categories less exposed to discussions re-
garding antibiotic use and resistance patterns might present
a different prescribing pattern.
In conclusion, the method used in this study is simple
and entails only a small extra workload for participants. It
was found feasible to perform this type of study for a
1-week period. The results gave more detailed information
regarding individual diagnosis compared to the regular
DPS. Also, additional information, such as duration of
symptoms before consultation and use of diagnostic tech-
niques, was acquired for further analysis. The intention is
to repeat the study using the same questionnaire form, for
example every other year, in order to closely follow changes
in diagnostic and treatment patterns for outpatients in
Sweden.
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Abstract
The aim of this study was to present and assess the treatment of infections in Swedish nursing homes. It included 58 nursing
homes with 3002 residents. During 3 months, nurses in the nursing homes recorded all infections requiring a physician’s
opinion. Of the 889 infectious episodes, 84% were treated with antibiotics. Many of the antibiotics were issued after indirect
contact with the physician (38%). Indications for antibiotics were in 55% of the cases urinary tract infections (UTI), in 17%
skin and soft-tissue infections and in 15% respiratory tract infections (RTI). The most common antibiotics were penicillins
(38%), followed by quinolones (23%) and trimethoprim (18%). For the major indication, lower UTI in women, half of the
cases were not treated according to the recommendations. The main concerns were length of treatment and overprescribing
of quinolones. For the second major diagnosis, pneumonia, the high use of doxycycline could be questioned. Continuing
education on infections and their treatment in nursing homes is needed. Training should preferably include both physicians
and nurses as a high proportion of antibiotics is issued without direct contact with the physician.
Introduction
Antibiotics use is a major risk factor for development
and spread of resistance, and increasing antibacterial
resistance is a worldwide threat to public health [1].
Although Scandinavian countries have relatively low
resistance rates, early actions are necessary as it
seems difficult to reverse resistance once it has
occurred [2].
In nursing home residents an association between
resistance and higher mortality has been found [3].
In addition, a recently published study from Norway
showed large variations in antibiotic sales to different
nursing homes [4]. The management of infections in
the elderly presents some particular difficulties
related to clinical presentation, diagnostic testing
and therapy [57]. Diagnostic uncertainty and
treatment of asymptomatic bacteriuria (ABU) are
examples of factors that might potentially contribute
to antibiotic overuse [6,8,9].
In Sweden a general decline in total antibiotic
sales had been observed since 1993 but, simulta-
neously, antibiotic sales had increased for patients
80 y of age and above [10]. Before this study little
information was available on the indications for
antibiotic treatment of infections in the elderly, in
particular in terms of the elderly living in nursing
homes. There were only a few regional studies
available [11,12].
The Swedish Antibiotic Nursing Home Trial
(SANT) is a collaborative project between Karo-
linska Institute, STRAMA (The Swedish Strategic
Programme for the Rational use of Antimicrobial
Agents) [13] and Apoteket AB (The National
Corporation of Swedish Pharmacies). SANT was
primarily started for 3 reasons: increasing antibiotic
consumption in the elderly, a lack of knowledge
about indications for treatment, and a lack of
national studies in the area.
The aim of this paper is to present the prescribing
of antibiotics and the indications for antibiotic
treatment in the elderly residing in nursing homes.
A secondary aim is to assess the antibiotic treatment
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 in relation to the recommendations for the major
indications.
Material and methods
This was a cross-sectional study. All registered
nurses charged with the medical responsibility for
nursing homes in Sweden were invited (n366) to
participate in the study. Those who took an interest
in the study forwarded the information to the nurses
at the nursing homes in their area, who then decided
to participate or not. Specialized nursing homes or
wards (e.g. oncology wards) were excluded.
Questionnaires and data collection
Data collection was practically handled by the nurses
at the nursing homes. A nursing home questionnaire
was used to collect background data. The following
variables were used: number of residents, gender
distribution of the residents and the approximate
proportion of residents that was expected to receive
immunization against influenza
Nurses in Sweden are generally not allowed to
prescribe antibiotics, so the nurses were asked to
complete a form for all patients with infectious
symptoms requiring a physician’s opinion. Data
were collected during 3 months, from mid-Septem-
ber to mid-December 2003. Recorded variables
included patient data, when and how the physician
was contacted, duration of symptoms before assess-
ment by a physician, a number of preset diagnoses
(as specified in Table I), diagnostic tests used,
prescribed antibiotic, treatment length, use of ur-
inary catheter and factors influencing the choice of
treatment.
There was also a question on whether the resident
had had the same kind of infection in the preceding 3
months, or had received any antibiotics during the
preceding 3 months prior to recording. Recurrent
UTI was defined as ]2 episodes within 6 months or
]3 episodes within 1 y (written on the form). The
form was a modified version of one previously used
in a diagnosis-prescription survey for outpatients in
5 Swedish counties [14].
The coordinator contacted all the study homes by
telephone once before, once during and once at the
end of the collection of diagnosis and prescribing
data, reminding the participants of important dates
and the proceedings of the trial. All the question-
naires and forms were pre-tested for face validity
during a full-scale pilot study involving 7 nursing
Table I. Recorded diagnosis, proportion treated with antibiotics and number and type of diagnostics used per diagnosis during 3 months
recording of infectious episodes in 58 nursing homes with 3002 residents in Sweden.
Diagnosis
Frequency;
n (% of total)
Antibiotics;
n (% of total)
Diagnostics
were useda Uristix CRP Culture
Other
diagnosticsb
URTI 18 (2.0) 10 (1.3) 9 1 6  2
Pneumonia 78 (8.8) 76 (9.9) 44 4 34 3 14
Atypical pneumonia 1 (0.1) 1 (0.1) 1  1  
Influenza 1 (0.1) 1 (0.1)     
Bronchitis, acute 12 (1.3) 11 (1.4) 6  5  1
Bronchitis, exacerbation of chronic bronchitis 11 (1.2) 11 (1.4) 4  2  3
Other, RTI 4 (0.4) 4 (0.5) 1 1   1
RTI, all 125 (14.1) 114 (14.8) 65 6 48 3 21
Lower UTI 317 (35.7) 270 (35.1) 298 252 23 147 56
Recurrent UTI 149 (16.8) 131 (17.0) 134 105 9 89 22
Upper UTI 21 (2.4) 18 (2.3) 19 17 5 7 7
Urethritis 2 (0.2) 1 (0.1) 1 1  1 
UTI, all 489 (55.0) 420 (54.6) 452 375 37 244 85
Erysipelas 40 (4.5) 38 (4.9) 14 1 10 2 4
Leg ulcers 28 (3.1) 27 (3.5) 18 1 1 18 
Pressure ulcers 12 (1.3) 11 (1.4) 7  2 5 1
Diabetic foot infection 4 (0.4) 4 (0.5) 2   2 
Other, skin 60 (6.7) 48 (6.2) 18  3 14 1
Skin/soft tissue infections, all 144 (16.2) 128 (16.6) 59 2 16 41 6
Fever of unknown origin 13 (1.5) 7 (0.9) 1 2 7 3 3
Virosis of unknown origin 3 (0.3) 3 (0.4) 1    2
Other infections 62 (7.0) 62 (8.1) 17 31 23 27 18
Missing diagnoses 53 (6.0) 35 (4.6) 16 10 6 9 1
Total (n889) 889 (100) 769 (100) 611 426 137 327 136
aAny discrepancies between this column and the sum of diagnostics are due to multiple diagnostic methods for the different diagnoses.
bDipslide culture, u-sediment, white cell blood count, X-ray, sedimentation rate, and diagnostics used 53 times.
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 homes. Some minor changes were made before the
main study.
Analysis and statistics
The questionnaires were sent to the coordinator for
entering and analysis of data using SPSS 10.0
software. The analysis of data mainly included
proportion of antibiotics used for different diag-
noses. For the major antibiotic indications, in
particular lower UTI in women, the choice of
antibiotics and duration of treatment was assessed
in relation to the recommendations. For precision of
the measurements, the 95% confidence interval is
presented. The standard errors used for calculating
confidence intervals are adjusted for clustering of
antibiotic prescribing over nursing homes. The
intracluster correlation coefficient, ICC, was 0.01.
The data from the pilot study were not included in
the analysis for this paper.
Ethics
The study was approved by the regional ethics
committee in Stockholm. Written informed consent
was obtained from participating nurses, physicians
and unit directors at the nursing homes.
Results
65 nursing home located in 37 municipalities in 15
out of 24 counties were eligible for participation at
the start of the study. Six nursing homes dropped out
during the data collection process due to insufficient
staffing, and 1 due to miscommunication.
The remaining 58 nursing homes had 3002
residents, of which 71% were women, with a mean
age of 84 y. The average nursing home had 52
residents (median 40, range 14207). According to
estimations by the contact nurses, approximately
71% of the residents would receive immunization
against influenza during 2003.
A total of 889 infectious episodes were recorded
during the 3 months of data collection among the
3002 residents. The mean age of the residents with
an infection was 85 y. Of all recorded episodes, 84%
were treated with 1 or more antibiotic (excluding
methenamine hippurate).
The antibiotic rate was 1.0 treatment per resident
and y. In 38% of the cases, the prescriptions for
antibiotics were issued during an indirect contact
with the doctor, i.e. by phone, fax or e-mail. A
specimen for culture was taken in 35% of the cases
where a new prescription of antibiotics was issued.
A probable diagnosis was noted in 82% of the
cases. Few cases were handled by ‘wait-and-see’ or
referral (9% and 4%, respectively). It was common
for the patients to have had the same kind of in-
fection during the preceding 3 months (36%) and/or
to have been treated with antibiotics during the
preceding 3 months (43%). Diagnosis and diagnos-
tics are presented in Table I. The distribution of
antibiotics for RTI, UTI, skin and soft-tissue infec-
tions and other infections is presented in Table II.
The most common indications for antibiotics were
UTIs (Table II). Men and women had the same rate
of UTI (0.69 episodes per elderly and y). Diagnos-
tics were used in most episodes (Table I). In 49% of
the cases, a urine sample was taken for culture before
issuing new antibiotics for UTI. The most common
antibiotics prescribed for UTI were quinolones
(34%).
It was noted that 88% (95% CI 0.790.97) of the
quinolones prescribed to elderly women with a UTI
(n85) were used for lower or recurrent UTI. Of
the 489 episodes of UTI, 212 had received anti-
biotics during the preceding 3 months and 211 had
had the same kind of infection during the preceding
3 months.
For the major diagnosis, lower UTI in women
(n226), approximately half  54% (95% CI 0.46
0.62) of the cases were not treated according to
the recommendations. Either first-line antibiotics
were not chosen (29%, 95% CI 0.210.36) and/or
the treatment length deviated from the guidelines
(47%, 95% CI 0.390.55). Of the 106 women with a
non-recommended treatment length, 101 were trea-
ted too long. However, it is important to stress that
men with lower UTI and incorrect treatment length
in general received too short a treatment (39/40).
The main antibiotics for lower UTI in women were
pivmecillinam (32%), trimethoprim (30%) and qui-
nolones (29%). Nitrofurantoin was only used in 8
cases. The treatment length was usually 7 or 10 d
(56% and 13%, respectively). Treatment for 5 d or
less only occurred in 9% of the treatments.
For skin and soft-tissue infections, a specimen for
culture was taken in 24% of the cases before issuing
a new antibiotic. Isoxazolylpenicillins were most
commonly used (Table II). The duration of treat-
ment was mainly 10 d (61%) and long-term treat-
ment was rare (5%). Local treatment with fucidic
acid represented only 1% of the treatments for skin
and soft-tissue infections. Only 1 case was treated
with a macrolide.
Among RTIs, the major diagnosis was pneumonia
(Table I). A concomitant chronic obstructive pul-
monary disease or multiple diagnoses possible was
noted for 5 of these cases. Almost all cases of
pneumonia were treated with antibiotics, most often
with a tetracycline (33%) followed by penicillin V
(25%) and amoxicillin (20%). In 34 cases, a CRP
Antibiotics in nursing homes 395
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 was obtained and it was above 50 in 24 of these cases
(Table I). The pneumonia cases were significantly
older than other cases with a mean difference of 2 y
(95% CI 0.14.4). Pneumonia was more common in
men than in women (0.21, 95% CI 0.170.24),
pneumonias per residing male and y compared to
0.07 (95% CI 0.050.10) among women. The most
common duration of treatment was 10 d (48/63
cases).
Discussion
This is the first study on infectious episodes, which
includes nursing homes, from a wide variety of
locations in Sweden. A UTI was the most common
indication for antibiotics and a quinolone was then
most often the drug of choice. A large proportion of
prescriptions of antibiotics was issued by the physi-
cian through an indirect contact with the nurse.
The antibiotic prescription rate found in this study
(1.0 per resident and y) was a little lower compared
to results published earlier where it has varied
between 1.1 and 1.9 treatments per resident and y
[11,12,15].
The proportion of antibiotics that was issued after
an indirect contact with the physician, 38%, ex-
ceeded the figure found for outpatients in general
in the More and Romsdal prescription study by
Rokstad and Straand, 1997 (25%) [16]. This could
be a potential risk for irrational prescribing of
antibiotics, which in the long run could have
negative effects on the resistance pattern for com-
mon pathogens in the nursing home setting.
In 2003, the recommended antibiotics for lower
UTI in women, in Sweden, were pivmecillinam,
nitrofurantoin or a cephalosporin for 57 d, or
trimethoprim for 35 d. Approximately half of the
cases of lower UTI in women were not treated
according to these recommendations. Quinolones
are only recommended for upper UTI and compli-
cated UTI (including men). In this study, the use of
quinolones was more frequent than in earlier studies
in Sweden [11,12,17]. In studies from Norway on
antibiotics in nursing homes, nitrofurantoin has been
used to a much higher extent, whereas the use of
quinolones has been small [4,15].
Asymptomatic bacteriuria is known to be very
common in nursing homes, in particular in elderly
women, which might lead to diagnostic problems,
especially in patients with decreased cognitive func-
tion [8,9]. Our data do not allow an evaluation of the
diagnostic procedure or the outcome of treatment,
but it would be important to discuss with staff how
diagnostics are used and interpreted. Even though
most UTI was diagnosed in women, the UTI rate
was equal for men and women.
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 Pneumonia was common, equivalent to 113
episodes per 1000 nursing home residents and y.
The choice of antibiotics could be discussed. Dox-
ycycline is not a first-line drug for pneumonia in
Sweden. Considering the aetiology, penicillin V
should be the most prescribed antibiotic followed
by amoxicillin [18]. A concomitant chronic obstruc-
tive pulmonary disease could justify the choice of
doxycycline but this was only noted for a few cases.
Although the reasons for the high doxycycline use is
beyond the scope of this paper, doxycycline might
have been preferred because of practical advantages
such as a small tablet taken once daily or a wish to
cover more uncommon agents.
The use of antibiotics for skin and soft-tissue
infections were mainly in line with current recom-
mendations. Isoxazolylpenicillins dominated the pre-
scribing pattern and the use of cephalosporins and
macrolides was found to be low. Locally adminis-
tered antibiotics and long-term treatment with anti-
biotics for skin and soft-tissue infections was not
common.
The antibiotic prescribing for infections in nursing
homes shown in this study, especially the high use of
quinolones, could be a potential risk for the spread
of resistant bacteria [19]. Spread of resistant clones
has been shown to occur within nursing homes
as well as between different health care facilities
[1921]. However, since the aim of this study was
not to assess the ecological situation in nursing
homes, we did not collect data on resistance.
Few nursing homes dropped out during the data
collection. As the study included a large number of
nursing homes of different sizes, from both rural and
urban locations, the results can give an indication of
the general situation in Swedish nursing homes. In
this study only the infectious episodes, where the
nurses considered a physician’s opinion necessary,
were recorded. This may lead to differences in the
number of registrations and type of contact depend-
ing on the knowledge of the nurse or the availability
of the physician at the different nursing homes. The
extent to which we may have missed cases cannot be
assessed. Such cases are more likely to have gone
untreated, so the overall effect on the results would
probably be an overestimation of antibiotic treat-
ment. The limitations of this study are mainly
associated with 1) the validity of the diagnoses; the
nurses recorded the doctor’s diagnosis and there
were no explicit criteria for the different diagnoses.
In addition, it is possible that a diagnosis has
been set after decision on treatment, in a manner
to justify the treatment, which would lead to an
underestimation of ‘outside guideline’ antibiotic use
[22]; 2) difficulties in assessing the appropriateness
of the prescribing of individual cases; 3) lack of
evidence-based guidelines for treatment of infections
in the elderly in general, and in nursing homes in
particular; as there was no document containing
official national, consensus guidelines on antibiotic
use in nursing homes, the research group reviewed
and discussed the available guidelines for outpatients
in general and eventually consented to a proposal of
antibiotic guidelines for UTI, skin and soft-tissue
infections and pneumonia. The acknowledged
guidelines were mainly based on current national
and/or regional recommendations and/or material
from STRAMA, Swedish Medical Products Agency,
Apoteket AB, Svenska infektionsla¨karfo¨reningen
(Swedish Association for Specialists in Infectious
Diseases) and local Drug Therapeutic Committees.
There is a need for updated, nationally accepted
guidelines for the treatment of the most common
infections in nursing homes. Special attention should
be given to the treatment length for UTIs and the
possibly irrational use of quinolones and doxycy-
cline. The high proportion of antibiotics issued
during indirect contact with the physician raises
some concern about the management of infections
in the elderly, and stresses the need to involve the
nurses in education on antibiotic treatment as well.
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Abstract
Background: Urinary tract infection (UTI) is a common indication for antibiotic treatment in 
the nursing home setting, but the role and responsibilities of the different categories of staff in 
the prescribing process of antibiotics needs to be further explored. 
Objective: The aim was to explore experiences and perceptions of the nursing home staff 
about urinary tract infections and their part in the antibiotic prescribing process.
Methods: Mixed methods design. The qualitative part was five focus group discussions 
(FGDs) with 10 nursing assistants, 10 nurses and six general practitioners (GPs) with 
experience from nursing homes. The focus group discussions were tape-recorded and 
transcribed verbatim. The data was analysed by content analysis influenced by the framework 
approach. The quantitative part was a knowledge- and attitude questionnaire about UTIs. 163 
of 165 nurses and 35 of 41 GPs responded to the questionnaire when they took part in an 
intervention study about infections and antibiotic prescribing in nursing homes. The 
questionnaire was used as method triangulation for the FGDs. 
Findings: The theme that emerged was “Interpersonal relations, timing and setting – the main 
determinants for management of UTIs and antibiotic prescribing in nursing homes.” The 
categories that were discerned during the analysis were: “Symptoms of urinary tract infections 
– clinical signs and attitudes”; “What leads to antibiotic prescribing”; “Communication 
between the staff concerning infectious symptoms” and “Hygiene in the nursing home 
setting”. This expresses that collaboration, communication, when the infection occurs, 
organisation and location have a perceived impact on the decision making process in the 
management of UTI in the nursing home.  
Background
Urinary tract infections, UTI, are one of the most common indications for antibiotic treatment 
in the nursing home setting (Nicolle et al. 1996, Loeb et al. 2001, Blix et al. 2007, Pettersson 
et al. 2008). Inappropriate antibiotic prescribing concerning UTI has been shown, which 
could lead to negative consequences in form of bacterial resistance, which can render 
previously treatable infections untreatable (Jones 1987, Nicolle 1996, Takahashi 2004). 
Antibiotics are often prescribed for non-specific indications (Boscia and Kaye 1987, Nicolle 
2002) although no relationship between bacteriuria and symtoms such as anorexia, fatigue, 
malaise or weakness have been shown (Warren et al.  1991). Difficulties encountered by the 
2
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nursing home staff in management of UTI in the elderly are mainly related to difficulties in 
eliciting information about symptoms because of cognitive impairment (Juthani-Mehta 2007). 
Presence of incontinence is also frequent which further complicates a diagnosis (Offermans 
2009, Omli 2010). The presentation of symptoms in the elderly also seems to be different 
from symptoms in younger adults (Gavazzi and Krause 2002). A high prevalence of 
asymtomatic bacteriuria, which should not be treated with antibiotics, also adds to the picture 
of complexity, which gives urinary dipsticks low positive predictive value in this population 
(Nicolle 1993, Hedin 2002, Arinzon et al. 2009). Consequently, the predictive value of 
bacteriuria in residents with fever, without catheter, is only 10 percent (Orr et al. 1996).  
Pyuria, which is present in 90 percent of those with bacteriuria is not a predictor for 
symtomatic UTI (Boscia et al.1989).
There has been a decrease in persons from 65 years in Sweden, who live permanently in 
special forms of housing, including nursing homes, from 115 000 (7.5%) in 2002 to 95 400 
(5.7%) in 2009 (SOS 2011). A reform was introduced for geriatric care in 1992 leaving the 
responsibility of geriatric long-term care to the municipalities instead of the County Councils, 
that are responsible for all other outpatient and inpatient care. The categories of health care 
staff in nursing homes are nursing assistants, nurses and general practitioners. The main tasks 
for the nursing assistants are: caring, housekeeping, medical, social and administrative tasks 
and social pedagogy (SOS 2006). The situation for the nurses changed after the reform from 
work in close collaboration with the general practitioner to work mainly on their own with 
responsibility for a large number of patients (Kapborg and Svensson 1999). Nurses are not 
formally authorised to prescribe antibiotics for systemic use. Although The National Board of 
Health and Welfare have descriptions of the competence required for registered nurses, RNs, 
there are no clear national definitions of functions and tasks for RNs in municipal elderly care 
(Svensson 2002) and there are only a few studies on their work situation in Sweden (e.g. 
Josefsson et al. 2007). General practitioners are not employed by the municipalities and the 
County Councils are responsible for all health- and medical care provided by the general 
practitioners (Akner 2004). 
The role and responsibilities in relation to antibiotic prescribing among the different 
categories of staffs present in the nursing home needs to be further explored and defined.
3
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The main aim of this study was to explore experiences and perceptions of the nursing home 
staff about urinary tract infections and their role in the antibiotic prescribing process.
Methods 
A mixed methods design was chosen (Onwuegbuzie and Teddlie, 2003). Mixed methods 
research has been defined by Tashakkori and Creswell (2007) as “research in which the 
investigator collects and analyzes data, integrates the findings, and draws inferences using 
both qualitative and quantitative approaches or methods in a single study or a program of 
inquiry”.
FGDs were chosen as the qualitative approach. FGDs captures interaction between 
participants in a way that individual interviews do not. Similarities and differences in views 
among the participants become more apparent through the interpersonal communication in the 
group (Freeman 2006). As statistical representativeness is not the aim of focus group research, 
a purposive sampling model was chosen (Kitzinger 1995). The participants were chosen to 
represent the different categories of health care staff working in nursing homes i.e nursing 
assistants, nurses and general practitioners. In order to be able to share their experiences one 
requirement for the participants was that they needed to have some practical, own experience 
from working in nursing homes. Each focus group was chosen to be homogenous to 
encourage mutual interaction during the sessions (Kitzinger 1995, Freeman 2006). 
Participants were recruited from nursing homes in two municipalities in the northern part and 
one municipality in the southern part of Sweden. In the written invitation participants were 
told that the purpose of the meetings was to discuss the role of the staff in management of 
infections in residents and to discuss about experienced infectious cases. The focus groups 
were held in settings where the participants felt comfortable to talk. 
EP is a pharmacist by profession, CL is a research nurse, SF is a social scientist with a PhD in 
Public Health and CSL is a pharmacist and professor and research group leader for Medicines 
in the Health System – focusing antibiotics at Karolinska Institutet. The moderator, EP, used a 
written discussion guide with open-ended questions, developed by EP and the research group. 
The semi-structured guide also included probe questions to be used by the moderator if the 
discussion faded. The main items were “infections and elderly”, “difficulties in treating UTI 
in elderly”, “hygiene” and “management of infections – anything you wish to change in your 
nursing home?”. The role of the moderator was to encourage all participants to share their 
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views, listen and to use exploratory probing questions (Murphy 1992). One observer took 
notes during the discussion to capture the atmosphere and expressions. The discussions were 
audio taped and then transcribed in verbatim by two assistants. The transcripts were checked 
against the audiotape by EP.
The data was analysed by content analysis influenced by the five different stages in the 
framework approach (Ritchie and Spencer 1993). 1) Familiarisation by listening to the tapes, 
reading the whole transcripts and the observational notes several times and making own notes 
in the material 2) Identifying a thematic framework by noting key issues and referring to the a 
priori aims of the study 3) Indexing all the data by noting parts with the same content in the 
margin 4) Charting by cutting and pasting and colouring the parts with similar content that 
was indexed in the previous stage from different FGDs (decontextualisation) 5) Mapping and 
interpretation where focus went back to the aim and once again the data was interpreted as a 
whole. The theme emerged from reading the transcripts interpretively over and over again 
looking for an essence in the material (Morse J, 2008). The last step could also be seen as a 
form of recontextualisation – to ensure that the categories and patterns that have been derived 
from the data still agreed with the context from where they were collected. Considerations 
have been taken to extensiveness of comments concerning a topic and negative cases i.e. an 
effort to find elements in the data that do not support or even contradicts the patterns found. 
The quantitative part of the study was a questionnaire, which focused on knowledge and 
attitudes about UTI and its treatment. This questionnaire was sent to 165 nurses and 41 GPs at 
nursing homes that participated in an educational intervention study concerning infections in 
nursing homes (Pettersson et al. 2008). The sample for the questionnaire was thus completely 
separate from the focus group participants. 163 nurses and 34 GPs responded anonymously to 
the questionnaire. The relevant parts for this paper was collected during the baseline phase of 
the intervention study and included i) four dichotomous statements - true or false ii) Two 
four-point Likert scale statements – graded from totally agree to totally disagree. The 
statements are added to the information obtained from the focus group discussions as a 
method triangulation to increase the credibility and thus trustworthiness of the study (Lincoln 
and Guba 1985). 
The collection and analysis of the qualitative and quantitative data were carried out separately 
and the results were related to each other during the interpretation of the findings. 
5
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Findings 
Five FGDs were performed: two with five nursing assistants; two with five nurses; and one 
with six GPs, table 1. The first three took place during 2003 and the last two during 2004. All 
participants had experiences from working in nursing homes. Table 2 presents an overview of 
the results from the quantitative questionnaire. The quantitative data has been related to the 
corresponding findings from the focus group discussions and are presented together with the 
qualitative findings below. 
The main theme that emerged from the focus groups was: “Interpersonal relations, timing and 
setting – the main determinants for management of UTIs and antibiotic prescribing in nursing 
homes.” 
Interpersonal relations refer to the relationship, communication and interaction between the 
members of the staff and relations between the staff and the resident and their relatives. Social 
factors that were addressed during the focus group discussions were colleagues behaviour, 
which was described both as perceived actual and perceived ideal behaviour by many 
examples. Both general practitioners and nurses described a pressure to act upon the 
information given to them from other staff members, residents or relatives and sometimes this 
pressure was specifically a demand for antibiotics. Whether you know the patient or staff that 
you were communicating to was mentioned as important factors for your own action. 
Timing refers to when the change in health status occurs, which could have perceived 
consequences for the actions taken. 
Setting refers to organisational and structural factors of the nursing home for example 
availability of dipsticks, disinfection alcohol and location such as proximity to health care 
centers/GPs. Nursing assistants described organisational problems to comply with hygiene 
guidelines, such as availability of working clothes, disposable aprons, gloves etc. This was 
also sometimes referred to as economic factors i.e. priorities done by the managers of the 
nursing home units. The reform was only mentioned in a positive way by the GPs who meant 
that it improved the availability of nurses at the nursing homes, although the GPs themselves 
perceived that their own hours dedicated to nursing homes decreased.  
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The categories that were discerned during the analysis of the focus group discussions were:
- Symtoms of urinary tract infections – clinical signs and attitudes 
- What leads to antibiotic prescribing? 
- What does a positive dipstick or positive urine culture mean? 
- Communication between the staff concerning infectious symptoms 
- Hygiene in the nursing home setting 
These categories are described below and followed by citations from the participants, where 
NA is nursing assistant, N is nurse and GP is general practitioner. NA 4C is thus interpreted 
as Nursing assistant C in focus group number 4 (chronological order).  
Symtoms of urinary tract infections – clinical signs and attitudes 
All groups described the multifaceted picture of symtoms of urinary tract infections in the 
nursing home setting. Interpretation of non-specific changes in health status can be difficult 
because of cognitive impairment in the nursing home residents. The symtoms range from 
specific clinical urinary tract symtoms such as urgency, frequency and dysuria to non-specific 
signs as foul-smelling urine, confusion, falling, aggression and agitation.  
”Many of our elderly they don’t react with fever, they just fall or get confused. It is other 
symptoms.” [N 3F] 
”we have a lady who /…/ sees dogs and cats around her bed. /…/ and that is the first sign – so 
there is nothing else to do but prescribe antibiotics.” [N 5E]
 “...well, I had one who always started singing (the children’s song) Baa Baa Black Sheep”. 
[NA 4C] 
They all described differences in management of these different symptoms from GPs treating 
merely all conditions to other GPs with a more restrictive attitude towards treatment.  
”We have got the answer (from the GP) that: - I don’t treat foul-smell”. [N 3B] 
7
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”The staff usually came to me and said: -Now we have to treat with something because there 
is foul-smelling urine. At the hospital we had a GP, who used to say: -Is it the patients or the 
staff we should treat?” [N 5E]
The presence of non-specific symptoms, sometimes as the only sign of UTI, was also 
supported in the questionnaire, table 2, statement 1 where 94% of the GPs and 90% of the 
nurses agreed to that confusion can be the only sign of an UTI in the elderly.
What leads to antibiotic prescribing? 
Fever is naturally a trigger for antibiotic prescribing. However, 97% of the GPs and 85% of 
the nurses did agree that fever does not have to be present to prescribe antibiotics (table 2, 
statement 2). Influences from other members of the staff and residents’ relatives to take urine 
samples and to treat with antibiotics are experienced in different ways.
“It is easier to wait and see if you know the persons involved than if the GP is completely 
unknown to the nurse, the residents and the relatives. Then it is easier just to prescribe.” [GP 
2D]
“It is easier to ‘wait and see’ if they call a Sunday night than if they call a Friday night – then 
you prescribe antibiotics.” [GP 2F] 
The nurses have a gatekeeping role concerning inititation of treatment of infections in the 
nursing home setting. This is acknowledged by all groups although the general practitioners 
refer to it as a middle role between the nursing assistants and the general practitioners. The 
GPs did not see this role as a problem as long as there is a concensus between the different 
categories of staff on how to manage infections. 
 “I believe that a nurse that wants the patient to get a treatment achieves this by describing 
(the symtoms/health status) in a certain way. I am totally convinced. This is part of the 
interplay we have – nothing strange with that, really.” [GP 2B] 
This might however be a problem when there is temporary staff involved as there seem to be 
differences in how the staff acts if they know the people involved. 
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”Well, it is even so that you prescribe antibiotics by phone if they say that there is a foul-
smelling urine and fever.” [GP 2 F] ”…but the difference is that it is easier to wait and see or 
refrain from treatment if you know somebody than if a total stranger, maybe both the patient, 
the nurse and relatives are strangers (to you) /…/.” [GP 2D] 
 ”If you call the on-call duty and bring out the problem, you will get what you want.” [N 5B] 
In contrast to the FGDs neither the nurses nor the GPs acknowledged the nurses as having a 
key role in the antibiotic prescribing process in the quantitative questionnaire. 56% of the GPs 
and 73% of the nurses totally disagreed to the statement that the nurse decides when to treat 
an UTI, table 2 statement 5. 82% of the GPs and 91% of the nurses totally disagreed to that 
the nurses decides the type of antibiotics, table 2 statement 6.
What does a positive dipstick or positive urine culture mean? 
Both the nurses and the GPs discussed about asymptomatic bacteriuria (ABU) while the 
nursing assistants did not. The general practitioners are the only ones actually referring to it as 
ABU. The nurses sometimes referred to it as silent UTI and agreed that this should not be 
treated with antibiotics. The magnitude of the problem and how to handle it is unclear, 
especially in diabetic patients. In practice it seems to be handled differently in different 
nursing homes. To decrease the number of urine samples taken, the nursing assistants do not 
have free access to dipsticks - it is sometimes kept in the nurses’ office.  
”Is it a UTI just because the patient has fever and positive nitrite when you know that maybe 
half (of the residents) have positive nitrite?” [GP 2E] 
”…but there are many saying that there is a very high percentage in elderly who has positive 
nitrite no matter if they are ill or not. ” [GP 2A] 
”…and the silent urinary tract infections we do not treat.” [N 3E] 
The opinion that bacteriuria should not always be treated, was supported in the quantitative 
questionnaire of 91% of the GPs and 86% of the nurses, table 2, statement 3. This also points 
out that GPs and nurses have knowledge about the existence of ABU in the elderly. 76% of 
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the GPs and 74% of the nurses also agreed that fever and symptoms of UTI is an indication 
for urine culture, table 2, statement 4. 
Communication between staff concerning infectious symptoms 
The communication between members of the staff was widely discussed during the sessions. 
Nursing assistants described a perceived ideal situation as beeing part of the team as they are 
the ones knowing “their” residents. However, the real situation is different and they can rarely 
have a direct communication with the GPs. Both GPs and nurses describe a pressure from the 
nurses and nursing assistants respectively, or relatives to prescribe antibiotics or at least act in 
some way on the information provided to them. Whether you know the patient or staff that 
you were communicating to was mentioned as important factors for your own actions. 
“The only one we talk to is the nurse, so we don’t have any contact with the GP. We talk to 
the nurse and then I expect that she forwards these thoughts.” [NA 1D]
”It is very different between different GPs. Some GPs treat everything so you hesitate (to 
contact them). If they do not have that many symptoms you can wait and see and give 
something to drink.” [N 5D] 
The GPs also described the communication: 
“So you describe a system where a nurse who doesn’t know the patient calls the GP, who 
doesn’t know the patient, who chooses to treat the patient without seeing the patient”. [GP 
2B] “Yes, that is an optimal situation (irony)”. [GP 2A]/.../ 
They were continuing their discussion on when to go to the nursing home and conclude that 
there are many determinants for when to and when not to go to the nursing home. 
“There are many factors /.../ . [GP 2B] “But if they call about a patient with positiv nitrite, 
some fever and foul-smelling urine - you wouldn’t get that much wiser by going there to see 
them.” [GP 2A] /.../  
[GP 2A] and [GP 2B] agreed that if it is another kind of infection, where there could be 
differential diagnoses, they should go and see the patient. 
10
EVOL2011-04-18 
The GPs seemed to wish for a consensus from the nursing home before the nurse contacted 
them so that the GP did not get several different stories. 
 “Some people exaggerate very much and others you know that when they say something it 
really means something, but it takes time to get to know the staff at the nursing home I have. I 
mean there is a staff - well I don’t know how many but I think there are 70-80 people working 
there during daytime.” [GP 2D] “/.../ because the nurse is usually in a middle function who is 
also dependent on what the nursing home staff reports.” [GP 2B] “/.../ but in practice it is 
impossible in a nursing home that there is a crowd with nursing assistants outside waiting to 
come in one after the other every time there is a new question. It simply doesn’t work.” [GP 
2A]
When the GPs talked about the communication with the staff at the nursing home they agreed 
with the following GP that: “It is important that the staff at the nursing home agree and 
provide us with one picture instead of calling us and presenting two different ideas /.../.” [GP 
2D]
Hygiene in the nursing home setting 
The groups with nurses and nursing assistants all seemed to be aware of the importance of 
correct hygiene practices. It is noteworthy how little the GPs talked about hygiene. Although 
there was awareness about hand hygiene there were practical problems mentioned remaining 
such as the many tasks for the nursing assistants. 
“We are dealing with garbage and wounds during the same day wearing the same clothes.” 
[NA 1B] 
All groups but especially the nurses described the conflict between the nursing home being a 
home for these very old, frail and multiple ill patients and at the same time the need to provide 
high quality of care. Critique against the reform was constantly woven into the discussions 
about hygiene expressed for example by a nurse assistant in focus group 4:
“And now, you are not wearing your working clothes at home, but I wear them when going 
home. That was absolutely unthinkable before (the reform) /.../ but now we have built up this 
new nice own-home-living home-environment and all. Then you start to wonder due to their 
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(the residents’) bad condition when they come here – are we going back to all that again. /.../ 
Back to when we had working coats, but now we need to integrate so it won’t show whether 
we are staff or relatives.” [NA 4B] 
“And then we go, wearing the same clothes as we had in the room with the one with stomach 
disease, to the dining room and serve them a meal there.” [NA 4D] 
“It has to be home-like living, but with certain additional items based on the needs, looking 
after (the residents) and so on. Otherwise it is kind of pointless having staff.” [N 5A] 
Discussion and methodological reflection 
The theme “Interpersonal relations, timing and setting – the main determinants for 
management of UTIs and antibiotic prescribing in nursing homes” expresses the latent content 
in the FGDs. The management of UTIs seems to be very dependent on who is involved in the 
process and how this is organized. Who is the nursing assistant, who is usually the first to 
observe the resident’s change in health status? Who is the nurse to whom the nursing assistant 
reports to? Who is the GP to whom the nurse reports to? Are they familiar with the resident 
and relatives to the resident? Have they been working together for a longer period of time? 
Where is the GP located? And eventually, what day of the week is it and what time is it when 
this change in health status is reported? 
Professional interpersonal relations is similar to the definition of collaborative practice 
provided by Way et al. 2000: “Collaborative Practice is an inter-professional process for 
communication and decision making that enables the separate and shared knowledge and 
skills of care providers to synergistically influence the client/patient care provided.” From our 
FGDs we also would like to add the interplay between the staff and the residents and relatives 
into the discussions about collaboration in the nursing homes. Collaboration, in particular 
between nurses and physicians, has been vastly studied in the literature but has mainly 
focused on collaboration itself and not the impact on outcomes of interests (Donald et al.
2010). In 2000, Zwarenstein and Reeves made an editorial in BMJ about the lack of evidence 
within the research field on collaboration and in 2009 they and Goldman J made an updated 
Cochrane review about practice-based interventions to change interprofessional collaboration, 
IPC (including randomised controlled trials to 2007). They suggested that practice-based IPC 
interventions could have a positive impact on processes and outcomes in healthcare, but the 
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review was only based on the five studies that met the inclusion criteria. They also stated that 
research within the field of IPC is complicated due to differences in terminology. Kvarnström 
et al. 2008 meant that health care professionals consider that difficulties in IPC could lead to 
perceived consequences in form of problems to provide the desired patient care. From 
prescribing practices in the long-term care setting it has been shown that poor collaboration 
between physicians and nurses was perceived as a barrier to optimal pain management 
(Kaasalainen et al. 2007).
Timing of the infection can affect the management according to the participants in the FGDs, 
but no evidence that would support that the on-call duty’s prescribing is different from the 
ordinary GP’s or that prescribing of antibiotics would be more frequent on Fridays than any 
other day of the week is available in the literature. 
That the setting makes a difference has also been indicated in a study from Boston, USA, on 
gerontological nurse practitioners perspectives on prescribing (Mahoney and Ladd, 2010). 
They included examples such as location of the patient and that nurses chose to work in 
places where the physicians were supportive. 
The categories represent the manifest content in the material. While interpreting the findings, 
attention was given to the picture provided by the group and an effort was put into 
distinguishing between opinions expressed in consensus within the group and opinions 
expressed in opposition within the group. It became clear that the participants in the focus 
groups experienced the nursing home setting in different ways. The nursing assistants talked 
about “their” residents and that it is important to care for them. Both nurses and GPs showed a 
more medical/clinical attitude towards the nursing home residents, which is probably due to 
the organisation of elderly care in the nursing homes and that the GP act as a consultant.
The description of symptoms of UTI in the elderly residents in nursing homes, ranging from 
the classic to the more non-specific signs, is in line with earlier results from FGDs with GPs 
and nurses in Canada (Walker 2000). However, the literature does not support prescribing of 
antibiotics on these non-specific symptoms (Boscia and Kaye 1987, Nicolle 2002, Warren et
al.  1991). 
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The key role of the nurses in the prescribing process of antibiotics in nursing homes described 
here have also been shown in Walker et al. 2000 and Loeb et al. 2005. The participants 
described a gatekeeping role both in terms of access and monitoring of others action. We do 
not intend to present an opinion on how the practice should be, but we believe it is important 
to acknowledge this situation and make policy decision from this stand point. If this is how 
the policy makers intended it to be, it is time to involve the nurses in nursing homes in more 
educational activities concerning infections and antibiotics and if this is contrary to the policy 
makers’ views, it is time to act upon that.
ABU was known to different extent in the different FGDs. In some of the groups there was an 
uncertainty about the prevalence of ABU and how to manage it practically. The high 
prevalence of ABU in the nursing home population (Nicolle 1993, Hedin 2002, Arinzon et al.
2009) and low predictive value of bacteriuria and pyuria for UTI need to be further 
communicated to the staff in the nursing homes (Orr et al. 1996, Boscia et al.1989). Standard 
screening test for bacteriuria and pyuria i.e. dipstick tests can be helpful for excluding UTI but 
not to confirm UTI in this population. 
The participants in all FGDs described communication with each other and with the residents 
and relatives. Relations, interaction and communication seem to play an important role in the 
management of infections. To our knowledge there are no studies focusing on the professional 
communication between nurses and nursing assistants in long-term care facilities. There have 
been studies on the nurse-physician communication in long-term care facilities (Cadogan 
1999, Kayser-Jones 1986 and 1989, Perkins 1993) and at least one focusing on telephone 
communication, although only including nurses (Tjia 2009). Barriers to communication found 
by Tija 2009: openness/collaboration, logistic challenges, professional respect/frustration,
language/mutual understanding and nurse preparedness, can also be found in this study 
although they are exemplified in different ways in our FGDs. Schmidt et al. 2002, conducted 
a study in nursing homes in Sweden on communication and quality of prescribing with a 
focus on psychotropic drugs, where it was noted that the quality of drug use was positively 
associated with both the quality of nurse-physician communication and with regular 
multidisciplinary team discussions about drug therapy. The same correlation could possibly 
be expected also for antibiotics. 
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The terminology for evaluative criteria in qualitative research is a little bit different both 
compared to quantitative research but also within qualitative research depending on the 
research tradition. Lincoln and Guba 1985, offers a theoretical framework where they mean 
that trustworthiness is established through credibility (internal validity), transferability 
(generalisability or external validity), dependability (consistency) and conformability 
(researcher bias and reflexivity). Other researchers such as Malterud 2001, who provides a 
comprehensive guideline for authors and reviewers within qualitative research, Mays and 
Pope 2000 and Graneheim 2004 have similar criteria for validity in qualitative research but 
the presentation differs. 
As this was an exploratory study, combining the descriptive results from the questionnaire 
with results from the focus groups, the findings are hypothesis generating rather than 
evaluative. Because the participation was voluntary the findings might only reflect opinions 
from those concerned in the area of infectious diseases. For our purpose it was important that 
all participants had substantial working experience from nursing homes. This could, however, 
have had an impact on the findings as the views can be different depending on years of 
experience. In addition we have not used observations, which mean that we do not have 
information about the actual behaviour; only how it is perceived by the staff represented in 
these focus groups. Some of the quotations also describe a perceived ideal behaviour. 
To increase credibility two types of triangulation was used: investigator or analyst 
triangulation and method triangulation. Both EP and CL has read and analysed the whole 
transcripts independently of each other and then discussed it in the research group to minimise 
interpretive bias of the findings (Patton 1999). Although integration of qualitative and 
quantitative data has been widely debated in social science, there can be advantages of 
combining the two on a chosen level (Onwuegbuzie and Teddlie, 2003). Ostlund et al. 2011 
implicated that mixed methods and triangulation can help the researchers within nursing- and 
health sciences to clarify, understand and make valid inferences of their results, although they 
acknowledge the presentation of mixed methods as challenging. The method triangulation 
provides means both for the researcher and the reader to make conclusions based on the two 
different methods. When the methods show confirmative results it does help to establish the 
credibility, but where the results diverge, an interpretation of the results are more difficult to 
make. For example the participants in the FGDs pointed out that the nurses have a key role in 
the antibiotic prescribing process, which was expected as it has been shown that the GPs in 
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38% of the times when an antibiotic is prescribed are not present at the nursing homes 
(Pettersson 2008). This was not supported in the questionnaire. However, the questionnaire 
did not allow elaborated answers, while the whole purpose of FGDs is to discuss and get as 
many views as possible. Here one needs to make a choice on which method is most valid for 
this particular question. We chose to emphasis the qualitative method here, but for other kinds 
of questions the correct choice might not be obvious. 
A negative- or deviant case analysis was also made to try to find elements during the 
discussions that did not support the emerging patterns, categories and themes. From the 
beginning there were more categories and examples of themes, which could be reduced after a 
more thorough analysis. The participants seemed comfortable with the choice of location for 
the focus group discussions and did not show any signs of not wanting to share their 
experience with us. Those who accept an invitation to participate in a focus group are 
probably more prone to tell their story then those that decline such an offer, which per se 
could limit the transferability of the findings. The geographical areas chosen for these FGDs 
and the fact that the participants had experience from municipality owned nursing homes 
could also have limitations on the transferability to metropolitan cities and privately owned 
nursing homes. With the data collected during a longer period of time, there was a risk for 
inconsistency in the data collection, but a shift in content of the FGDs was not noted and the 
same discussion guide and the same moderator was used for all sessions. 
Conformability is referring to in what way the researcher and research process have shaped 
the data. Malterud 2001 and Mays and Pope 2000, have among other researchers 
acknowledged that reflexivity, or how researcher perspective and position, influence the 
research process, interpretation, findings and conclusions and suggest means to address this. 
The method- and analyst triangulation and the description of the researchers’ professional 
background are means to make the presentation of the analysis more transparent to what 
might have had an influence on the data.  
In this study it was not possible to have the same sample in the focus group and the 
intervention study, from where the quantitative data was collected, as it could have affected 
the results of the intervention study, but for future research it would be interesting to see how 
interpersonal relations and communication correlates to the quality of antibiotic prescribing.
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Conclusions 
Interpersonal relations between the staff, residents and relatives, timing i.e. when the infection 
occurs and setting i.e organisation and location are perceived by the nursing assistants, nurses 
and GPs to be the main determinants in the management and antibiotic prescribing for UTIs in 
nursing homes. The nurses’ gatekeeping role in the prescribing process needs to be further 
explored and evaluated in order to effectively and in a patient safe manner manage UTIs in 
the nursing homes. 
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Table 1: Focus group sample 
Group Category of staff Number of 
participants 
and sex 
Age range Location 
1 Nursing assistants 5F 35-48 Norrbotten County 
2 General Practitioners 1F, 5M 43-52 Jönköping County 
3 Nurses 5F 52-61 Norrbotten County 
4 Nursing assistants 5F 35-60 Norrbotten County 
5 Nurses 5F 53-59 Norrbotten County 
Total participants = 26 (21F 5M) 
Table 2: Results, in numbers, from a knowledge and attitude questionnaire with 163 
nurses and 34 general practitioners, GPs.
Statement Profession Missing True False Do not know 
   
1. Confusion can be the only 
symptom in elderly with UTI 
GPs
Nurses 
0
1
32
147 
1
15
1
0
   
2. Fever is always present in UTIs 
that should be treated with 
antibiotics 
GPs
Nurses 
0
0
1
21
33
139 
0
3
   
3. Bacteriuria should always be 
treated
GPs
Nurses 
2
3
0
11
31
140 
0
4
   
4. If the resident have fever and 
symptoms of a UTI you should do 
an urine culture 
GPs
Nurses 
3
8
26
121 
5
36
1
3
Totally 
disagree
Disagree
in many 
cases
Agree in 
many
cases
Totally 
agree
5. In practice, the nurse decides 
whether or not to treat an UTI  
GPs
Nurses 
1
2
19
119 
7
22
6
12
1
8
6. In practice, the nurse decides 
which type of antibiotic that is 
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 Can a multifaceted educational intervention targeting both nurses and 
physicians change the prescribing of antibiotics to nursing home residents? 
A cluster randomised controlled trial. 
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Objective To assess the impact of a multifaceted educational intervention concerning 
treatment of infections in the nursing home setting. 
Methods Cluster randomised controlled trial. 58 nursing homes in Sweden were randomly 
assigned either to educational intervention or control. The intervention consisted of small 
educational group sessions with nurses and physicians, feedback on prescribing, presentation 
of guidelines and written materials. Primary outcome was proportion of quinolones prescribed 
for lower urinary tract infection, UTI, in women. Secondary outcomes were for all infections: 
number of UTIs per resident, proportion of recorded infections treated with an antibiotic, 
proportion of infections handled by physicians’ “wait and see”; and for lower UTI in women: 
proportion of nitrofurantoin.  
Results Of the 58 nursing homes, 46 completed the study. 702 and 540 infections were 
recorded pre- and post-intervention. Proportion of quinolones decreased significantly in 
intervention- and control group by -0.196 and -0.224 respectively (95% CI -0.338 to -0.054 
and -0.394 to -0.054) but the difference between intervention and control was not significant 
0.028 (95% CI -0.193 to 0.249).  The changes in proportion of infections treated with 
antibiotics and proportion of infections handled by physicians’ “wait and see”, was significant 
in comparison with controls: -0.124 (95% CI -0.228 to -0.019) and  0.143 (95% CI 0.047 to 
0.240). No intervention effect could be seen for the other outcomes. 
Conclusions The educational intervention had no effect on the primary outcome, but 
decreased the overall prescribing of antibiotics.  
 
Trial registration number: NCT01054677 at http://www.clinicaltrials.gov/  
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Inappropriate use of antibiotics is still a common problem in the nursing home setting 1-4 and 
can lead to adverse events for the consumers 5, development of resistance 6-8, increased 
mortality 9 and also excessive costs for the care providers 10. To address the problem of 
inappropriate prescribing, a multi-faceted educational intervention was developed. The main 
focus was on antibiotic treatment for lower urinary tract infection, UTI, in women, as it is the 
main indication for antibiotic treatment in nursing homes.3 Traditionally, physicians have 
been the target group for interventions concerning prescribing practices for urinary tract 
infections in outpatient care.11-13 However, as it was known that 38% of antibiotic treatment in 
nursing homes was initiated without direct contact with the physician, we decided to include 
the nurses in the intervention as well although they are not formally authorised to prescribe 
antibiotics for UTI.1 This was also supported in Loeb M et al, 2005.14 Changing professional 
practice is difficult and there is no universal recipe for success, but reviews suggest that multi-
faceted, active strategies have a higher likelihood of success than single interventions.15-16  
 
The aim of this paper is to present the evaluation of a multifaceted educational intervention on 
change in a predetermined set of outcomes concerning infections in the nursing home setting.  
Material and Methods 
We have adopted the CONSORT statement for reporting randomised controlled trials.17-18 
Additional information required for cluster randomised trials has also been reported in 
accordance with the extension to the CONSORT statement 2001, expressed in Campbell et al 
2004.19  
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This study is a cluster randomised controlled intervention study with two study arms i.e. 
intervention and control (figure 1). The nursing home was the unit of allocation and 
intervention, but in the analysis individual resident data was used allowing for clustering on 
the nursing home level.  
Participants/setting 
The research coordinator sent an invitation letter to all nurses charged with medical 
responsibility within local authority elderly care in Sweden, enquiring about participation in 
the study (n=366 at the time of invitation). The inclusion criteria were nursing homes where 
residents have a common dining room and staff, and a self-assessed stable staff situation. 
Exclusion criteria were specialised nursing homes or wards (e.g. oncology wards). For a 
flowchart of the trial, see figure 1. A pilot study including seven nursing homes preceded the 
trial. The aim of the pilot was to optimise the instruments and educational intervention and to 
enable us to do a sample size calculation. Nursing homes from different parts of Sweden were 
included in the main trial. Data from the pilot study was not included in the analysis of the 
main trial.  
Sample size calculation 
The number of clusters needed was calculated 20 as 25 in each arm to have 90% power to 
detect a 20% relative difference in prescribing of quinolones ( = 0.05), assuming a baseline 
rate of 4.5% quinolone users based on the pilot study and literature, average cluster size of 60 
residents, and a intracluster correlation coefficient, ICC, taken from literature of 0.05.21-22  
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During three months from September 15 to December 15, 2003 we collected baseline data. 
The parts of the trial relevant to this paper were: diagnosis-prescribing survey, (DPS) and a 
nursing home questionnaire (NHQ). For the DPS, the nurse responsible was requested to fill 
in a form for all patients with infectious symptoms requiring a physician’s opinion. Recorded 
information included patient age, sex, indwelling urinary catheter i.e KAD; if physician was 
present at the nursing home; the main infection, antibiotic treatment if prescribed, type of 
antibiotic and treatment length and factors influencing the choice of treatment or referral of 
the patient. If a resident had several diagnoses on one occasion, one form for each infection 
was recorded. As the purpose was not to assess the risk for infections in nursing homes, but to 
present changes in the prescribing pattern, recurrent infections were included. We focused on 
a predetermined set of outcome variables as indicators for a possible change. Proportion of 
quinolones for lower UTI in women was the primary outcome. Secondary outcomes were 
number of UTIs per resident; and for all infections: proportion of infections treated with 
antibiotics, proportion of infections handled by physicians’ “wait and see”; and for lower UTI 
in women: proportion of nitrofurantoin. The proportion of admissions to hospital was 
presented as an indicator for the adverse events of the intervention.  The NHQ was used to 
collect information on the nursing homes, as specified in table 1. Intervention was conducted 
from October 25, 2004 to January 21, 2005. From February 14 to May 16, 2005 we collected 
post-intervention data by using the same instruments as for baseline data collection. DPS and 
NHQ were repeated for the nursing homes and the results were compared with the baseline 
results.  
 
Table 1. Characteristics of intervention versus control nursing homes included in the analysis 
of the intervention effect, at baseline. 95% CI is presented.  
 
 Control nursing homes Intervention nursing homes 
Number of included nursing homes 20 26 
Number of residents 1143 1394 
Mean number of residents/nursing 
home 
57.2 (37.1-77.3) 53.6 (37.2-70.1) 
Age, mean 83.7 (82.6-84.9) 83.9 (82.0-85.8) 
Proportion of females 0.67 (0.64-0.71) 0.69 (0.64-0.74) 
Proportion UTI/ residents  0.15 (0.13-0.17) 0.14 (0.12-0.16) 
Antibiotic courses per resident and 
year, mean 
1.11 (0.13-2.10) 0.97 (0.14-1.79) 
Proportion of residents with 
indwelling urinary catheters 
0.08 (0.05-0.11) 0.07 (0.04-0.10) 
Proportion of residents immunised 
against influenza 
0.73 (0.61-0.85) 0.65 (0.51-0.78) 
Use of disinfection alcohol 
Litre/resident and month 
0.19 (0.09-0.28) 0.13 (0.08-0.18) 
Number of staff/resident   
 Physicians 
(h/week/resident)  
0.08 (0.06-0.10) 0.05 (0.03-0.07) 
 Registered nurses 0.08 (0.05-0.11) 0.08 (0.04-0.11) 
Nursing assistants 0.77 (0.56-0.98) 0.67 (0.54-0.79) 
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Random assignment 
In 2004, after the baseline DPS, the nursing homes were stratified into 3 equally sized groups 
based on the number of UTI/resident for each nursing home at baseline. To get a geographic 
spread of the intervention and control, the nursing homes were also divided into three 
geographical areas. The nursing homes within each of the nine final strata were randomly 
assigned to either intervention or control. EP performed a randomisation by computer where 
50% in each stratum were randomly selected to comprise the intervention group. 
Educational intervention 
The description of the intervention have been influenced by the framework for describing the 
key features of a quality improvement intervention published by Hulscher et al 2003, see box 
 
 1.23 The development of the intervention began with project group meetings, focus group 
discussions with physicians, nurses and nursing assistants working in nursing homes, and 
eventually evaluation of the intervention in the pilot study and revision before the main trial. 
In addition to feedback and references to available guidelines; structural, organizational and 
social barriers to change were discussed. Material for presentation was developed in the study 
group. To make the intervention more context-specific, the participating physician and 
hygiene nurse were local, and we also referred to guidelines from the local drug therapeutic 
committees. 
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Box 1. Educational intervention 
Main components of the intervention 
-2 sessions of voluntary continuing medical 
education 1.5 h each 
-2 to 3 external facilitators presented the 
guidelines and stimulated interactions between 
the participants: one pharmacist, one physician, 
and when possible a hygiene nurse. At least one 
of them was active in Strama-work.  
 -Educational materials -Leaflet on hygiene 
-Handouts during the sessions 
-Short written guideline for antibiotic 
prescribing  
 -Baseline results both written and verbal 
 
-Feedback on performance 
-Verbal summary at the end of the sessions 
Main content of the intervention 
-Feedback on baseline results 
-Guidelines on antibiotic prescribing for the 
most commonly encountered infections in 
the nursing home setting 
-Local pattern of antibiotic resistance 
-The content of the intervention was presented 
both verbally and in writing. 
Target group of the intervention 
-Nurses and physicians at the included 
nursing homes. Ranged from 2-13 
participants during the different sessions. 
-The nursing home was the cluster and unit of 
allocation, intervention and analysis 
Main outcome measures, proportions 
1. quinolones for lower urinary tract infections, UTI, in women 
2. UTI per resident 
3. antibiotic prescriptions for all infections 
4. physicians’ “wait and see” for all infections 
5. nitrofurantoin for lower UTI in women 
Evaluation of the intervention 
 - Differences before and after intervention 
for the main outcome measures. 
-A written evaluation of the training was also 
completed after the sessions 
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Recommended treatment for UTI in women were at the time for the trial, pivmecillinam or 
nitrofurantoin for 5-7 days and trimethoprim for 3-5 days (note: national guidelines were 
 
 changed in 2007). For patients with KAD, quinolones for 10 days was the recommended 
treatment.  
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Statistical analysis 
The nursing homes were analysed according to ITT with respect to allocation. However, a full 
application of intention to treat, ITT, analysis was not possible as complete outcome data was 
not available for all randomised nursing homes.24 What separates the analysis from a true ITT 
is that the evaluation of the intervention has been done for the 46 nursing homes remaining at 
follow-up i.e an available case analysis. All questionnaires were sent to the coordinator for 
entering, and analysis of data using SPSS 17.0 (at start 10.0) software. For precision of 
measurement, the 95% confidence interval, CI, is presented both for baseline characteristics 
and the main outcome variables. After baseline, the actual ICC for each variable was 
calculated in SPSS according to the mixed effect model. For the primary outcome, the 
calculated ICC was 0.03. All figures describing the intervention effect are adjusted for the 
design effect, which was calculated for each outcome variable. Deff = 1 + (n – 1)where is 
the ICC.25 A multivariable linear regression was performed in SPSS 17.0 to explore potential 
confounders: Residents’ age, availability of physicians, nurses and nursing assistants, KAD, 
volume of disinfection alcohol consumed and special needs of the residents. Special needs of 
the residents were calculated as: 1/7 x Hygprop + 1/7 x Clothprop + 1/7 x Movprop + 1/7 x Toiprop +
1/7 x Eatprop + 1/7 x Pressprop + 1/7 x LegProp. Hygprop is the proportion of residents not 
managing personal hygiene. Clothprop is the proportion of residents not managing clothing. 
Movprop is the proportion of residents not managing moving around. Toiprop is the proportion 
of residents not managing visits to the toilet. Eatprop is the proportion of residents not 
managing eating. Pressprop is the proportion of residents at the nursing home with pressure 
wounds. LegProp is the proportion of residents at the nursing home with leg ulcerations. The 
choice of items was influenced by Katz ADL score, but dichotomised to independent
 
 dependent. Two additional items: pressure wounds and leg ulcerations were added.26 We
chose an equal weight to each of these variables in t
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Ethical considerations  
The research was conducted in accordance with the Declaration of Helsinki. The study was 
approved by the Regional Ethics Committee in Stockholm (dnr 03-070). The head of all units 
involved in the project, as well as physicians and nurses, were asked to give their written 
informed consent. The participation was voluntary i.e. only nursing homes where the staff 
agreed to participate were included. After the end of the trial the control nursing homes were 
invited to a similar educational session as that for the intervention homes. 
Results
Baseline characteristics were similar for the intervention and control nursing homes (table 1). 
Antibiotic courses per resident and year; the immunisation rate; number of residents per 
nursing homes; the use of disinfection alcohol and availability of physicians and nursing 
assistants seemed a little bit higher in the control group, but all 95% CIs overlap. Of the 
original 58 nursing homes, 46 with a total of 2,511 residents remained at follow-up (figure 1). 
These nursing homes had at baseline 2,537 residents. Efforts were made to get details on the 
dropouts, but for three of them it was not possible. During the three months of data collections 
there were 702 infectious episodes recorded pre-intervention, compared to 540 post-
intervention. According to the attendance lists 164 people were exposed to the educational 
intervention of which 13 were general practitioners. 
 
For changes in the main outcome variables, see table 2. Proportions are presented with their 
95% CIs. Discrepancies between the denominator for each proportion and the respective 
number presented for all infections and lower UTI in women are explained by missing values. 
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The proportion of the primary outcome, quinolones for lower UTI in women, decreased 
significantly in both intervention- and control group by -0.196 and -0.224 respectively (95% 
CI -0.338 to -0.054 and -0.394 to -0.054). The difference in change between intervention and 
control was not significant 0.028 (95% CI -0.193 to 0.249).  The number of UTIs per resident 
decreased significantly in both intervention and control arm -0.031 and -0.070, but the change 
of 0.038 was not significant (95% CI -0.013 to 0.089). The proportion of infections treated 
with an antibiotic decreased significantly, by -0.124 (95% CI -0.228 to -0.019) in comparison 
with the control group. The proportion of infections handled by physicians’ “wait and see”, 
increased significantly in the intervention group compared with the control group by 0.143 
(95% CI 0.047 to 0.240). The proportion of nitrofurantoin prescribed remained the same in 
both groups, before and after the intervention. 
 
Parameter estimates for relevant explanatory variables in the multivariable regression on the 
primary outcome - proportion of quinolones for lower UTI in women: Intervention 0.163 
(95% CI 0.026 to 0.301); physician-hour per week 2.178 (95% CI 0.357 to 3.998) and special 
needs 0.115 (95% CI 0.036 to 0.194). 
Adverse events 
There was no increase in admissions to hospital in the intervention group. The number of 
admissions in 2003 was 15/311 for the control group and 15/355 for the intervention group. In 
2005 it was 5/203 for the control group and 20/299 for the intervention group. Change in 
control group -0.024, 95% CI -0.056 to 0.008 and change in intervention group 0.025, 95% CI 
-0.011 to 0.060.
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The educational intervention significantly changed the proportion in courses of antibiotics 
prescribed and it also influenced the proportion of infections handled by physicians’ “wait 
and see”. However, no intervention effect could be seen for the other outcomes including the 
primary outcome - proportion of quinolones prescribed for lower UTI in women.  
 
By giving information e.g on the prevalence of asymptomatic bacteriuria in the nursing home 
setting, we hoped to reduce the proportion of residents diagnosed and thus treated for an 
UTI.3,27 The educational intervention did not have the expected effect on this outcome. 
Availability of physicians could be a possible confounder. Sweden is a low-prescribing 
country with respect to antibiotics.28 It was thus expected to influence the pattern of 
prescribing towards the guidelines but not to reduce the total use of antibiotics, although this 
is what we eventually did. In clinical practice the result in this context would mean a decrease 
of approximately 6 courses of antibiotics over one year in a nursing home with 50 residents. 
A comparison with results from reviews of intervention studies of antibiotic practices are 
difficult to make as the studies included in the analysis mainly target outpatients; one of the 
most common disease targets being respiratory tract infections, RTI .15-16 Here the main 
indication is UTI, not RTI.  
 
The significant and clinically relevant change in the prescribing of quinolones, the primary 
outcome variable, cannot be attributed to the intervention. Multivariable linear regression 
showed that the intervention influenced the prescribing of quinolones but availability of 
physicians, and special needs were potential confounders. Concerning the quinolones there 
has been a rigorous work of drug therapeutic committees and Strama, the Swedish strategic 
 
 programme against antibiotic resistance, to reduce prescribing where it is not indicated. As an 
example, between 2003 and 2005 the quinolones decreased from 173 to 149 
prescriptions/1000/day in the age group 80 and over.
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29 No significant increase of 
nitrofurantoin could be seen. In a study on outpatient prescribing of nitrofurantoin in 2000, 
2002 and 2005 there was an increasing trend.30 The total nitrofurantoin use increased from 27 
prescriptions/1000/day in 2003, to 37 prescriptions/1000/day in 2005.29 A secular trend in the 
outcome variable could thus explain the lack of significant results for the quinolones. For 
nitrofurantoin, where there were very few cases, it is likely that the study was underpowered 
to detect any possible differences. The results have been adjusted for clustering. The 
questionnaires had been tested for face validity and feasibility during the pilot study. The 
educational intervention and the working methods had also been tested in the pilot study. We 
cannot be certain that the participants in the intervention were the same as the evaluated 
group, as we did not collect information on the identity of the prescribers. 
 
The modest effect of the intervention can have several explanations such as: i) low exposure 
to the intervention or that staff from two control homes also participated in the intervention, 
ii) a secular trend in the outcome variables. For feasibility reasons, the nursing homes did not 
receive the intervention at the same point in time and it was more than one year between the 
pre- and the post-intervention data collection. During this time there are changes in the 
nursing homes in staff and residents and factors outside the trial are given time to influence 
the outcomes. Contamination, which would dilute the intervention effect, also needs to be 
considered as nurses and physicians in one intervention home also could work in a control 
home. Hawthorne effect could also have affected the results if prescribing behaviour changed 
only because of the fact that the participants knew that they were being studied and not 
because of the intervention. For the quinolones this might have had an additive effect to the 
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secular trends described earlier. Seasonal changes in use of antibiotics are not likely to have 
an influence on the results in this trial as monthly sales statistics for ATC code J01 between 
2002 and 2004 for elderly above 80 years only range from 39.1 to 43.3 DDD/1000 
inhabitants. In addition the primary outcome for this trial concerned lower UTI in women and 
seasonal variations do not apply in a meaningful way to UTIs in this patient group. There was 
a wide geographic spread of nursing homes, which was desirable for high external validity, 
although this probably contributed to a higher dropout rate in our study. There were more 
dropouts in the control nursing homes and only 20 nursing homes remained for analysis, 
which raises the question of attrition bias. Experiences from the pilot study, where there were 
no dropouts, indicate that this difference could be explained by the absence of the coordinator 
in the control homes rather than that participants became weary of the study. An exploratory 
analysis at baseline showed that the outcomes in dropout nursing homes did not differ 
substantially to those of homes remaining during the whole trial (data not shown). Thus, the 
dropouts probably had little influence on the intervention effect. 
 
The antibiotic prescription rate at baseline in the nursing homes in this trial was a little bit 
lower compared to earlier studies (1.0 per resident and year compared to 1.1 - 1.9).1 This 
could be an indication of selection bias in the way that the nursing homes included in this 
study might be more interested in the area of infectious diseases and thus perhaps more 
restrictive to antibiotic treatment to begin with. It would then be difficult to show a 
statistically significant effect of an intervention as the changes would probably be small. 
 
A review in 2006 of educational interventions targeting antibiotic prescribing behaviour 
(mainly for respiratory tract infections) showed a median absolute effect of -8.9% 
 
 (interquartile range, IQR -12.4% to -6.7%). When targeting selection of antibiotics, the 
included interventions were considered effective with a median absolute improvement in 
prescribing of recommended antibiotics of 10.6% (IQR 3.4% to 18.2%).
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31 The effect of our 
intervention could thus be discussed. The results are in similar magnitude for total antibiotic 
use (-12%) and wait and see (14%), but the results for these secondary outcomes should be 
interpreted cautiously since there is a risk of type I error as we set the same significance level, 
0.05, for both the primary and secondary outcomes for ease of interpretation and comparison 
with other studies. 
 
In conclusion the intervention had a modest effect. The primary outcome, proportion of 
quinolones, decreased significantly but it cannot be attributed to the intervention. It was 
possible to decrease the proportion of infections treated with an antibiotic and to increase the 
proportion of infections handled by physicians’ “wait and see” through a multifaceted 
educational intervention targeting both nurses and physicians. One of the questions raised, 
which is essential for future educational interventions, is whether it is the nurse or the 
physician who has most influence on antibiotic use in the nursing home setting.  
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